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Retrieval Analysis of Necropsy Total Hip Replacements: Considerations Beyond
the Implant
Abstract
Introduction. Total hip arthroplasty (THA) surgery is one of the most commonly performed and
successful orthopedic procedures in the United States. More than 300,000 primary THAs and 40,000
revision THAs performed in the United States every year. While the need for revision surgeries can stem
from a variety of causes, there have been, to the author’s knowledge, no studies attempting to correlate
the concentrations of certain inflammatory cytokines to metal ion concentrations found in the tissue
surrounding the implant, amount of polyethylene wear, or strength of the interface of the modular taper.
The purpose of this study was to begin to look at those factors to see if any were indicative of implant
survivorship, as well as to see if metal ion content contributes to implant longevity. The testing for this
group of well-functioning implants will be useful as a baseline when comparing the same types of testing
for failed implants.
Methods. A total of nineteen cadaveric total hip implants were obtained from two sources, the Medical
Education and Research Institute (Memphis, TN) and RestoreLifeUSA (Elizabethton, TN). The bearings for
these implants were either metal on polyethylene or ceramic on polyethylene. Synovial fluid and tissue
samples were taken from the joint for testing. Head dissociation was performed, in which an Instron 4505
was used in accordance with ASTM Standard F2009-00 to remove the head from the stem of the implant,
recording force. Corrosion scoring was performed on taper surfaces by three scorers. The polyethylene
acetabular liner was measured on the superior side with a micrometer to determine how much material
loss was evident compared to the inferior side. These three values were then correlated to the testing
performed using the synovial fluid and tissue. The synovial fluid was analyzed for inflammatory cytokines
IL-6, MCP-1, IL-1β, MIP-3α, M-CSF, IL-8, IL-2, and TNF-α using a premixed Luminex screening assay. These
results were given in picograms per milliliter. An anterior and posterior synovial tissue sample was
analyzed for the presence of metal ions cobalt, chromium, and titanium using Inductively Coupled Plasma
Mass Spectrometry (ICP-MS). All of these results were compiled and analyzed together to search for
potential correlations.
Results. There were no significant differences in dissociation forces between the groups of implants with
head corrosion score 1 and head corrosion score 2. The comparison of MCP-1 to the dissociation force
produced a correlation coefficient of 0.64 (p-value 0.05) and the comparison of MIP-3α to the
dissociation force produced a correlation coefficient of 0.67 (p-value 0.03). However, when the graphs of
these correlations were observed, it seemed likely that this correlation was due to one sample pulling the
graph in a positive direction which is demonstrated by the 95% confidence interval (CI) of the correlation
coefficient (0.011 to 0.90 for MCP-1, and 0.069 to 0.91 for MIP-3α). When comparing polyethylene wear
to the inflammatory cytokine concentrations, no significant correlations were seen. There was a positive
correlation between cobalt and chromium levels and dissociation force (r=0.56 for cobalt, r=0.66 for
chromium), and a negative correlation between titanium levels and dissociation force (r=-0.30). The
positive relationship was opposite of what was expected, as more metal debris should mean the implant
surfaces are losing material, which should therefore decrease the strength of the taper connection. The
95% confidence interval for the correlation coefficients included zero for cobalt and titanium, and was
fairly wide for chromium (0.11 to 0.90). When observing cytokines and metal ion presence, most
relationships were very scattered with low correlation coefficients. However, for cobalt, strong positive
relationships were seen for IL-6 (r=0.67, CI: 0.19 to 0.89), MCP-1 (r=0.76, CI: 0.33 to 0.93), and MIP-3α
(r=0.60, CI: 0.066 to 0.86). When looking at confidence intervals, there seemed to be a mild correlation
between cobalt and IL-6 and a moderate correlation between cobalt and MCP-1. No meaningful
relationships were seen for any cytokines with chromium or titanium, so it may be useful to select

cytokines known to be responsive to those two metals in particular for future studies. When comparing
metal levels between the two corrosion levels seen in the heads, there were no statistically significant
differences in any of the metals between implants with a corrosion score of one and those with a
corrosion score of two.
Discussion. This study was limited by the fact that the sample size for this study was very low. With only
nineteen total implants, it was difficult to draw meaningful conclusions. Additional implants are being
recruited in order to increase this sample size for future studies. Additionally, it was difficult for
meaningful correlations to be seen when comparing any factor to the inflammatory cytokine
concentrations, as these values were clustered around the lower limit of detection. However, this was
expected with well-functioning implants. While it is difficult to draw meaningful conclusions when used as
a correlation, this data will be useful when comparing cytokine concentrations of a group of failed
implants. This group is able to serve as a baseline value for each type of testing performed, and will help
to make sense of the same testing of failed implants in the future.
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ABSTRACT
Introduction. Total hip arthroplasty (THA) surgery is one of the most commonly
performed and successful orthopedic procedures in the United States. More than 300,000
primary THAs and 40,000 revision THAs performed in the United States every year.
While the need for revision surgeries can stem from a variety of causes, there have been,
to the author’s knowledge, no studies attempting to correlate the concentrations of certain
inflammatory cytokines to metal ion concentrations found in the tissue surrounding the
implant, amount of polyethylene wear, or strength of the interface of the modular taper.
The purpose of this study was to begin to look at those factors to see if any were
indicative of implant survivorship, as well as to see if metal ion content contributes to
implant longevity. The testing for this group of well-functioning implants will be useful
as a baseline when comparing the same types of testing for failed implants.
Methods. A total of nineteen cadaveric total hip implants were obtained from two
sources, the Medical Education and Research Institute (Memphis, TN) and
RestoreLifeUSA (Elizabethton, TN). The bearings for these implants were either metal
on polyethylene or ceramic on polyethylene. Synovial fluid and tissue samples were
taken from the joint for testing. Head dissociation was performed, in which an Instron
4505 was used in accordance with ASTM Standard F2009-00 to remove the head from
the stem of the implant, recording force. Corrosion scoring was performed on taper
surfaces by three scorers. The polyethylene acetabular liner was measured on the superior
side with a micrometer to determine how much material loss was evident compared to the
inferior side. These three values were then correlated to the testing performed using the
synovial fluid and tissue. The synovial fluid was analyzed for inflammatory cytokines IL6, MCP-1, IL-1β, MIP-3α, M-CSF, IL-8, IL-2, and TNF-α using a premixed Luminex
screening assay. These results were given in picograms per milliliter. An anterior and
posterior synovial tissue sample was analyzed for the presence of metal ions cobalt,
chromium, and titanium using Inductively Coupled Plasma Mass Spectrometry (ICPMS). All of these results were compiled and analyzed together to search for potential
correlations.
Results. There were no significant differences in dissociation forces between the groups
of implants with head corrosion score 1 and head corrosion score 2. The comparison of
MCP-1 to the dissociation force produced a correlation coefficient of 0.64 (p-value 0.05)
and the comparison of MIP-3α to the dissociation force produced a correlation coefficient
of 0.67 (p-value 0.03). However, when the graphs of these correlations were observed, it
seemed likely that this correlation was due to one sample pulling the graph in a positive
direction which is demonstrated by the 95% confidence interval (CI) of the correlation
coefficient (0.011 to 0.90 for MCP-1, and 0.069 to 0.91 for MIP-3α). When comparing
polyethylene wear to the inflammatory cytokine concentrations, no significant
correlations were seen. There was a positive correlation between cobalt and chromium
levels and dissociation force (r=0.56 for cobalt, r=0.66 for chromium), and a negative
correlation between titanium levels and dissociation force (r=-0.30). The positive
relationship was opposite of what was expected, as more metal debris should mean the
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implant surfaces are losing material, which should therefore decrease the strength of the
taper connection. The 95% confidence interval for the correlation coefficients included
zero for cobalt and titanium, and was fairly wide for chromium (0.11 to 0.90). When
observing cytokines and metal ion presence, most relationships were very scattered with
low correlation coefficients. However, for cobalt, strong positive relationships were seen
for IL-6 (r=0.67, CI: 0.19 to 0.89), MCP-1 (r=0.76, CI: 0.33 to 0.93), and MIP-3α
(r=0.60, CI: 0.066 to 0.86). When looking at confidence intervals, there seemed to be a
mild correlation between cobalt and IL-6 and a moderate correlation between cobalt and
MCP-1. No meaningful relationships were seen for any cytokines with chromium or
titanium, so it may be useful to select cytokines known to be responsive to those two
metals in particular for future studies. When comparing metal levels between the two
corrosion levels seen in the heads, there were no statistically significant differences in
any of the metals between implants with a corrosion score of one and those with a
corrosion score of two.
Discussion. This study was limited by the fact that the sample size for this study was very
low. With only nineteen total implants, it was difficult to draw meaningful conclusions.
Additional implants are being recruited in order to increase this sample size for future
studies. Additionally, it was difficult for meaningful correlations to be seen when
comparing any factor to the inflammatory cytokine concentrations, as these values were
clustered around the lower limit of detection. However, this was expected with wellfunctioning implants. While it is difficult to draw meaningful conclusions when used as a
correlation, this data will be useful when comparing cytokine concentrations of a group
of failed implants. This group is able to serve as a baseline value for each type of testing
performed, and will help to make sense of the same testing of failed implants in the
future.
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CHAPTER 1.

INTRODUCTION

Significance of Research
Total hip arthroplasty (THA) surgery is one of the most commonly performed and
successful orthopedic procedures in the United States [1]. The first THA in the United
States was performed in 1960, and currently more than 300,000 THAs are performed in
the United States every year [2]. While many of these operations are successful, there are
almost 40,000 revision THAs performed in the United States annually as well. This
number has been steadily rising over the last twenty years, and is predicted to continue to
do so, making it a growing problem. The average hospital charge for a revision THA is
$54,600 [3]. These revision surgeries can be due to a variety of causes, but so far there
have been no studies attempting to correlate the concentrations of certain inflammatory
cytokines to metal ion concentrations found in the tissue surrounding the implant, amount
of polyethylene wear, or strength of the interface of the modular taper. The purpose of
this study was to begin to look at those factors to see if any potential biomarkers could be
identified as indicative of implant survivorship, as well as if metal ion content contributes
to implant longevity. The testing for this group of well-functioning implants (implanted
at time of death) will be useful as a baseline when comparing the same types of testing
for failed implants.
Relevant Anatomy
The hip joint is one of the largest joints in the human body, comprised of the
femur and acetabulum. It is considered to be a ball-and-socket joint, in which the ball is
the femoral head and the socket is the acetabulum of the pelvis. The femur is the only
bone in the upper leg, while the acetabulum is a deep, semispherical socket cavity in the
hip located at the convergence of the ilium, ischium, and pubis (Figure 1-1). The
acetabulum is where the femoral head articulates during hip motion.
A THA may be necessary because of a variety of causes, but one of the most
common causes is osteoarthritis, where the cartilage that typically cushions the joint is
worn away. When the cartilage is worn away, the femoral head and acetabulum directly
articulate against one another, causing pain and stiffness. Osteoarthritis accounts for 70%
of THA cases [1]. Another frequent cause of hip pain can be post-traumatic arthritis,
which occurs when an injury to the hip causes the cartilage to become damaged, and
therefore, stiffness and pain occur. Trauma can lead to articular cartilage loss,
incongruency, or cartilage damage which can then lead to painful joint articulation,
resulting in the need for a total hip arthroplasty. Rheumatoid arthritis, aseptic necrosis, or
the presence of a tumor are other factors that can be indicative of the need for a total hip
replacement [4].
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Figure 1-1.

Ball and socket joint of the hip

Reprinted with permission.

Foran, J.R.H. Total Hip Replacement. OrthoInfo 2015 8/2015 [cited 2016 8/18/16].
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Total Hip Arthroplasty
Surgical Procedure
A THA is performed by an orthopedic surgeon, and can be done with either an
anterior or posterior approach. The implant used for a THA has several components: a
femoral stem which goes into the femur, a femoral head which is placed onto the stem via
an impaction, the acetabular shell which sits in the reamed acetabulum, and the
polyethylene liner which fits in the shell and is the articulating surface for the femoral
head (Figure 1-2).
The two most popular surgical approaches used in THA are the posterolateral
approach and the direct anterior approach [5]. For the posterolateral approach, the patient
is first anchored in a lateral decubitus position. An incision is then made that is centered
over the greater trochanter and is curved posteriorly, beginning at a point level with the
anterior superior iliac spine. The incision is then extended distally to the center of the
greater trochanter along the femoral shaft, and to a point ten centimeters distally from the
greater trochanter. The subcutaneous tissues are dissected and the gluteus maximus is
split in the direction of its fibers. The fascia is dissected away from the fibers of the
gluteus medius, and a Charnley or other self-retaining retractor is inserted beneath the
fascia lata at the level of the trochanter, ensuring the sciatic nerve is not entrapped
beneath the retractor. The external rotators are divided as closely to the femur as possible,
and the rotators are reflected posteriorly to protect the sciatic nerve. The interval between
the gluteus minimus and superior capsule are bluntly dissected. Hohmann retractors are
placed superiorly and inferiorly to obtain exposure of the entire capsule. The capsule is
divided adjacent to its femoral attachment and preserved for later repair. A Steinmann pin
is inserted into the ilium superiorly to the acetabulum to determine leg length. The hip is
then dislocated posteriorly by flexing, adducting, and gently internally rotating the hip,
and the head is lifted out of the acetabulum with a bone hook. The bony margins of the
rim of the acetabulum are exposed to facilitate proper placement of the acetabular
component, and any osteophytes that protrude beyond the bony limits of the acetabulum
are removed. The acetabular component, and later, the femoral component, are then
implanted as described in the following paragraphs [5].
The direct anterior approach requires less muscular dissection than the posterior
approach, and is done with the patient in the supine position. A skin incision is placed
lateral to the interval between the tensor fascia latae and sartorius to avoid injury to the
fibers of the lateral femoral cutaneous nerve, which may be variable in its course. The
fascia is divided over the muscle belly of the tensor fascia latae fibers to stay lateral to the
lateral femoral cutaneous nerve. The interval between the tensor fascia latae and the
sartorius is bluntly dissected with an index finger so that the femoral neck can be
palpated through a thin layer of fat overlying the anterior capsule. Blunt curved retractors
are placed superior and inferior to the femoral neck, taking care in the placement of the
retractor beneath the rectus femoris to avoid injury to the femoral nerve and vessels. The
anterior hip capsule is divided into a T or H shape for later repair. An in situ osteotomy is
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Figure 1-2.

Components of total hip prosthesis

Reprinted with permission.

Foran, J.R.H. Total Hip Replacement. OrthoInfo 2015 8/2015 [cited 2016 8/18/16].
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performed of the femoral neck and the femoral head is extracted with a corkscrew. The
acetabulum is then exposed by placing curved retractors distal to the transverse
acetabular ligament and along the posterior rim of the acetabulum to displace the femur
posteriorly. The proximal femur is exposed by placing the operated limb in a figure-offour position and adducting the femur slightly while externally rotating 90 degrees. The
femur is elevated laterally and upward with a bone hook, taking care not to trap the femur
behind the acetabulum. Often, additional soft-tissue release is needed at this stage to
avoid excess retraction force. The acetabulum and femur are then prepared and
components are implanted as described in the next paragraph [5].
The acetabulum is prepared by excising the ligamentum teres and any remaining
soft tissue. The floor of the acetabulum is palpated, and the acetabulum is prepared with
reamers, going from smaller to larger reamers in the direction of the opening face of the
acetabulum. Reaming is complete when all cartilage has been removed, the reamers have
cut bone out to the periphery of the acetabulum, and a hemispherical shape has been
produced. When inserting the acetabular cup, the surgeon ensures the patient is in a true
lateral position to avoid the cup being placed in a retroverted position. The acetabular
component that is the same size as the last reamer can then be implanted with fixation, or
a slightly oversized component (1 to 2 mm) can be press-fit for more initial stability. The
acetabular component is attached to the positioning device which is used to ensure the
proper angle of inclination and anteversion is obtained. Once the correct position has
been determined, the acetabular component can be impacted until there is intimate
contact between the implant and the bone. Screws may be used for ancillary fixation,
preferably in the posterosuperior quadrant. Once screws are implanted, the stability of the
component is tested, looking for no detectable movement between the implant and bone.
Once this is complete, the polyethylene liner can be implanted, ensuring that no soft
tissue is interposed between the liner and its metal backing, as this can interfere with the
locking mechanism. Next, to prepare the femur, a laparotomy sponge is placed in the
acetabulum to protect the component. The proximal femur is exposed by internally
rotating the femur so the tibia is perpendicular to the floor. A retractor is used to deliver
the proximal femur, and any remaining soft tissue is excised from the neck. A box
osteotome can be used to remove any remaining portions of the lateral aspect of the
femoral neck and medial portion of the greater trochanter to allow access to the center of
the femoral canal. Once the femur is exposed, a small reamer is inserted slightly posterior
and lateral on the cut surface of the femoral neck. The reamer is aimed down toward the
medial femoral condyle and is progressed to the appropriate depth. This continues with
progressively larger reamers until diaphyseal cortical reaming is felt. The proximal
portion of the femur is prepared by removing residual cancellous bone along the medial
aspect of the neck with precision broaches. The broach is placed in the same alignment as
the axial reamers and the handle is pushed laterally during insertion to ensure enough
lateral bone is removed and to avoid varus positioning of the stem. The broach can be
rotated to control anteversion. From the posterior approach, the medial aspect of the
broach must be rotated toward the floor. Progressively larger broaches are used,
maintaining identical alignment and rotation. The final broach is seated where it is axially
stable within the canal with the cutting teeth at or below the level of the preliminary neck
cut. The fit of the broach within the canal is assessed, and when adequate stability has
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been obtained the final adjustment of the neck cut is made. The final level of the neck cut
should correspond with the measured distance above the lesser trochanter established in
preoperative templating. The trial neck component is selected and impacted, and the
center of the femoral head is evaluated with radiographs. The hip is moved through a
range of motion, noting any areas of impingement between the femur and pelvis or
between the prosthetic components. If the stability is acceptable, the hip is redislocated
and the head is lifted out of the acetabulum. The trial components and broach can then be
removed, and the appropriately sized femoral component can be gently impacted down
the canal. An audible change in pitch can be detected as the stem nears final seating. The
stability of the stem is assessed when exposed to rotational and extraction forces. If
satisfactory, the debris are wiped from the Morse taper and the segment is dried and the
prosthetic head is affixed to the neck with a single blow over a plastic-capped head
impactor. The stability is again confirmed through a full range of motion, and if
satisfactory, the patient can be closed [5].
Design History
The earliest recorded attempt at a hip replacement surgery was in Germany in
1891 [6]. The methodology and results were presented at the 10th International Medical
Conference by Professor Themistocles Glück. In his method, ivory was used to replace
the femoral heads for patients in which tuberculosis had destroyed their hip joints. Later,
in the late 19th and early 20th centuries, surgeons tried interpositional arthroplasty in
which various tissues (fascia lata, skin) were placed between articulating hip surfaces for
arthritic hips [6]. In 1925, Marius Smith-Petersen created the first mold arthroplasty made
of glass. His design featured a hollow hemisphere to fit over the femoral head to provide
a smooth surface for movement. Although glass is biocompatible, it was not able to
withstand the forces the hip joint experiences and shattered. The same surgeon later went
on to try stainless steel and created the first total hip replacement that was fitted to bone
with bolts and screws [9]. In 1953, George McKee was the first to regularly use a metalon-metal prosthesis [7]. He began by using a modified Thompson stem, which was a
cemented hemiarthroplasty used in femur neck fracture treatment, with a cobalt-chrome
socket for the acetabulum. One study showed a 28 year survival rate of 74% for this
method, but by the mid-1970s this method became unpopular due to local effects of metal
particles seen in revision surgeries for failure [9]. Sir John Charnley is considered to be
the father of the modern THA [8]. He created a low friction arthroplasty in the early
1960s which consisted of three parts: a metal femoral stem, a polyethylene acetabular
component, and acrylic bone cement. This is very similar in principle to many of the
designs being used today [9].
Current Design
During typical gait, the human hip is placed under cyclic loading in which it is
subjected to forces that are three to five times the force of body weight [1]. This force can
increase up to twelve times body weight for more strenuous activities, such as running or
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climbing [1]. Therefore, the design of a hip implant must be able to be subjected to this
excess loading over many cycles without wearing down, while still approximating the
normal motion of the natural hip joint. Most of the acetabular cup portions of these
implants consist of a metal alloy lined with ultrahigh molecular weight polyethylene.
These acetabular components are not typically cemented, but they can be. The acetabular
cups can also be created with an outer porous metal shell in which bone can grow into.
Previous designs did not have the polyethylene component between the acetabular cup
and the femoral head, but the two metal components articulating with one another created
high friction, resulting in metallic wear debris and then loosening of the implants as well
as pseudotumors, therefore, a polyethylene liner is now typically used between the
acetabular shell and femoral head [10]. As for the femoral component, it is typically
made of metal such as stainless steel, titanium, or cobalt-chromium in order to ensure
long-term resistance to breakdown from loading [1]. Titanium alloys are frequently used
in hip stems and other bone-contacting components because of their good bone-ingrowth
qualities, and high strength. Titanium alloys may not be as useful in bearing components,
because they have a higher wear rate. Cobalt-chromium-molybdenum (CoCrMo) alloys
are frequently used in these articulating components because of their high wear
resistance, but they do not have as good osteointegration qualities so they are lessfrequently used in the bone contacting components [10].
A design feature that is common in all modern total hip replacements is a
modular, Morse-like taper between the neck and head. The neck component is typically
part of the stem, unless a second modular taper is used between the stem and neck,
therefore making the neck its own separate piece. Designs have moved away from the
dual-taper system, however, due to higher risk of wear and metallic debris. The taper
consists of the male portion, called the trunnion, and the female portion, called the bore
[11]. With the head-neck modular taper, the head is fixed to the neck potion by an
interference fit, where the surgeon applies one impaction to the head in order to secure it.
This modularity allows the surgeon to have many options in regards to designing an
implant specific to the patient. It allows for different materials to be combined, specific
head sizes to be used, and allows the surgeon to control leg length through neck offset.
The strength of the connection between the neck and head is dependent on the taper
design, the impaction force, and the condition of the taper surfaces [12].
In the trunnion portion of the taper, there are varying design parameters that differ
depending on the type of implant being used. The bore portion of the taper must be
designed to fit the trunnion, so it is mostly dependent on the trunnion design used. These
two parts are not interchangeable between different manufacturers or implant designs,
they are created to be placed together. The characteristics that can vary with the trunnion
are the taper angle (2α), the diameters of the proximal and distal portions, the
engagement length, and the head-neck offset (Figure 1-3). Typical top (D1) and bottom
(D2) diameters used are 12/14 mm, 11/13 mm, 9/10 mm, and so on. These dimensions
are disclosed by companies, however, most consider the taper angles to be proprietary
and will not disclose the specific angles. The taper angles are typically only a few
degrees. The engagement length, L, is the axial length of the taper that makes contact
across the junction. While each of these factors can play a role in implant design, there
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Figure 1-3.

Schematic drawing of taper geometry

Reprinted with permission.
Gilbert, J., S. Mali, and S. Sivan, Corrosion of Modular Tapers in Total Joint
Replacements: A Critical Assessment of Design, Materials, Surface Structure,
Mechanics, Electrochemistry, and Biology, in Modularity and Tapers in Total Joint
Replacement Devices. 2015, ASTM International.
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are also differences in how the materials are processed. For example, manufacturers may
vary the roughness of the surfaces using purposefully machined microgrooves or microridges. These ridged or microgrooved geometries are typically used to accommodate
ceramic heads in order to avoid overloading the ceramic and thus decreasing the potential
for burst fracture. Another variation in taper design is the head-neck offset. These can
change depending on what best fits the needs of the patient, and refers to the position of
the center of the head component and the most proximal taper trunnion position. The
ability to vary head-neck offset is necessary in order to limit joint laxity, restore leg
length, and for acetabular and femoral rotation center alignment [10].
Current Materials Used in Bearing Articulation
Metal on Polyethylene
Metal-on-polyethylene bearings are the most commonly used today, and provide a
safe, predictable, and cost-effective bearing for the majority of patients [13]. This
particular design features a metal stem and metal acetabular cup, with a polyethylene
liner on the inside of the acetabular cup (Figure 1-4). The main concern with this type of
material is polyethylene debris, as when the body encounters this debris the macrophages
secrete inflammatory cytokines which can be mediators of bone lysis and can lead to
aseptic loosening and eventually, implant failure. The presence of these debris can be
minimized with the irradiation of polyethylene with gamma particles [9].
Metal on Metal
Metal-on-metal bearings fell out of favor in the 1970s due to concerns of the
bearings producing metal ions, leading to metallosis and in severe cases, pseudotumors,
but came back into production in the late 1980s through the early 2000s. A problem that
may occur from metal on metal bearings is possible hypersensitivity reactions and
loosening of the implant [7]. Patients receiving this type of implant also tend to have
cobalt and chromium ion blood levels that are three to five times higher than those seen
in patients with metal on polyethylene prostheses (Figure 1-5) [9]. However, this may
not be true if there is excessive mechanically assisted crevice corrosion between the
cobalt chromium head and stem of a metal on polyethylene bearing. In these instances,
the metal on polyethylene bearing may exhibit similar increased metal levels to metal on
metal [10].
Ceramic on Ceramic
Half of the THAs performed in central Europe use ceramic heads, but in the UK
and USA this rate drops to less than ten percent. Implants using these materials were
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Figure 1-4.

Cup portion of metal-on-polyethylene prosthesis

Reprinted with permission.
Knight, S.R., R. Aujla, and S.P. Biswas, Total hip arthroplasty–over 100 years of
operative history. Orthopedic reviews, 2011. 3(2): p. 16.

Figure 1-5.

Metal on metal total hip prosthesis

Reprinted with permission.
Knight, S.R., R. Aujla, and S.P. Biswas, Total hip arthroplasty–over 100 years of
operative history. Orthopedic reviews, 2011. 3(2): p. 16.
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designed to address to problems of friction and wear reported with other materials [13].
This design is typically a ceramic head on a metal stem, and a ceramic lining in the
acetabular cup (Figure 1-6). The ceramic used typically consists of either alumina or
zirconia. The benefits of ceramic-on-ceramic bearings include the high level of hardness,
scratch resistance, and the inert nature of debris. These prostheses have also been shown
to have improved lubrication, lowering the coefficient of friction and improving wear
resistance. These are often a good choice for young, active patients. Excellent surgical
technique is needed with this type of implant, because chipping of the contact surface
with insertion of the prosthesis or dislocation are possible and can lead to third body wear
[9].
Ceramic on Polyethylene
Ceramic-on-polyethylene bearings are one of the most popular bearing types used
today[14, 15]. This particular design features a metal femoral stem with a ceramic
femoral head and a polyethylene liner on the inside of the acetabular cup. Similar to
metal on polyethylene, one major concern with these materials is the generation of
polyethylene debris. When the body encounters this debris, the macrophages secrete
inflammatory cytokines which can be mediators of bone lysis and can lead to aseptic
loosening and eventually, implant failure. The presence of these debris can be minimized
with the irradiation of polyethylene with gamma particles [9]. Another risk with using
ceramics in total joint replacements is the risk of a burst fracture occurring. If there is any
defect in the material upon implantation, that can lead to failure of the femoral head. The
femoral head can also experience a burst fracture if it receives a strong impact, such as
experienced in car accidents. In cases of burst fracture, the implant must be revised.
However, regardless of this potential failure mechanism, this type of bearing is frequently
used in THAs because of its strong performance history. This type of bearing also
eliminates the production of metallic debris from the taper connection, as this connection
is now a ceramic with a metal instead of a metal on a metal.
American Society for Testing and Materials (ASTM) Standards for Testing of
Bearing Materials
Each of the bearing materials mentioned above goes through a series of testing
before being implemented as a material used in total joint replacements. ASTM Standard
F732-00 provides a test method for evaluating the wear properties of combinations of
materials that are being considered for use in bearing surfaces of total joint prostheses. It
describes various tests to quickly and reliably screen material combinations for wear
performance in different orthopedic wear applications prior to beginning joint simulator
testing. The recommendations from this standard describe test methods to evaluate the
friction and wear properties of materials being considered in bearing surfaces for total hip
replacement. The standard provides a baseline of wear quantities per year clinically for
the results of the testing to be compared to (69 ± 33 mm3 per year for 22 mm heads, 85±
33 mm3 per year for 28 mm heads, and 90 ± 44 mm3 per year for 32 mm heads). It also
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Figure 1-6.

Ceramic on ceramic total hip prosthesis

Reprinted with permission.
Knight, S.R., R. Aujla, and S.P. Biswas, Total hip arthroplasty–over 100 years of
operative history. Orthopedic reviews, 2011. 3(2): p. 16.
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provides a wear method of 7 mm3 per million cycles for ultra high molecular weight
polyethylene (UHMWPE). The standard also defines how to prepare the polymer
specimen and the counterface, as well as the specifications for the wear machine. The
standard allows for load to be variable as long as it correlates to existing contact stresses.
It also specifies that motion between the specimen and counterface must be
multidirectional to achieve wear rates and wear mechanisms that are representative of
those in a fixed-bearing ball-cup application, and recommends the system includes a
cycle counter and strain gauge to measure friction. This standard is consistently used in
the development and testing for new bearing materials, and has already been completed
for the bearing materials used in total hip replacements discussed previously [16].
Taper Wear
One problem that is evident at the taper component of hip implants is
Mechanically Assisted Crevice Corrosion (MACC). MACC is a process in which
mechanical wear or deformation affects the alloy surface electrochemically. The
contributing factors to MACC are varied and include material and mechanical factors,
transport factors, solution chemistry inside and outside of the taper, electrochemical
factors, and biological factors [10]. This type of corrosion is also frequently called
fretting corrosion and is seen very commonly in retrieval analysis of devices using the
Morse- type taper. A study done by Gilbert showed that 16 to 35 percent of 148 retrieved
total hip implants had signs of moderate to severe corrosion at the head-neck taper
connection [10]. Some of these implants consisted of a Ti-6Al-4V-alloy stem and a
cobalt-alloy head, and some consisted of both a cobalt-alloy stem and neck. Based on a
literature review, the prevalence of MACC ranges from 10 to 100% of retrieval
specimens, each with varying degrees of damage. The damage amount is dependent on
alloy composition, femoral head diameter, implantation time, and physical and
mechanical factors [11].
The alloys used in the taper connection have oxide films that form on them that
are a few nanometers thick. These oxide films give the alloys their corrosion resistance
and serve as kinetic barriers to help keep corrosion rates low [17]. They have the ability
to repassivate, or self-heal, in milliseconds if the conditions are favorable. However, the
crevices found in the taper portion of the implant are typically at a higher risk of stress
and micromotion which necessitates constant repassivation of the oxide layer, causing
loss of oxygen and leading to a lower pH, high chloride content, and more negative
potentials. These conditions can prevent the oxide films from self-healing, which can
allow for the release of cobalt and chromium ions. Additionally, the formation of oxides
(Cr2O3 and CoO) leads to a continuation of the oxide layer being unable to heal and can
cause more oxides and ions to be released [10].
Disassembly testing has been done to determine how assembly procedure and
material combination can affect the disassembly force of a modular total hip implant. A
study by Rehmer found that disassembly forces were directly related to the assembly
forces [18]. It also found that multiple impactions during assembly did not increase the
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taper strength [18]. Although this finding is interesting, the study discussed in this thesis
did not know the impaction force of the received implants, so therefore one cannot say
whether the disassembly forces are due to the taper conditions or assembly forces and
thus, must just be taken as a stand-alone force value.
ASTM Standard for Determining the Axial Disassembly Force of Taper
Connections
ASTM Standard F2009-00 was created in order to establish a standard
methodology for determining the force required to disassemble tapers of implants that are
otherwise not intended to release. This method is used primarily for evaluation of metal
and ceramic head designs and provides a means to measure the axial locking strength of
the taper connections. For this testing, the cone portion of the assembly should be
constrained by suitable features, and the modular head should be disassembled with a
cage that provides even contact around the inferior edge of the head. The testing machine
should deliver a tensile force at a constant displacement, and should have load monitoring
and recording. For the disassembly, special care should be taken to ensure no artificial
hoop stresses or bending moments are placed on the taper assembly, and a displacement
rate of 0.05 mm/s should be used. The load and displacement should be recorded
continuously until the test is complete [19].
Inflammatory Cytokines
With THA being as widely performed an operation as it is, a focus has been
placed on periprosthetic osteolysis and aseptic loosening, because both of these factors
can cause loosening of the implant, and therefore, failure. Metal debris from THAs can
stimulate the production of polymorphonuclear leukocytes and macrophages locally,
which can lead to a foreign body chronic inflammatory reaction [20]. When looking at
the soft tissue around loose prostheses, there is often a foreign body reaction because of
polyethylene, metal, or polymethylmethacrylate (PMMA) particles. Macrophages,
lymphocytes, and other immune cells are activated when wear debris are introduced into
the tissue, and these can secrete inflammatory cytokines such as interleukins,
chemokines, interferons, and tumor necrosis factors in response to these debris.
There are several cytokines known to be involved in macrophage activation via Tcells. Macrophages are phagocytic cells that are found in tissues or as mobile white blood
cells, especially at infection sites. The cytokines that are known to do this are interferongamma (IFN-gamma) and interleukin-2 (IL-2) [21]. These have each been shown in the
literature to be present during macrophage activation. Another category of cytokines is
those present in inflammation. These have been well-documented in literature and
include tumor necrosis factor alpha (TNF-α), macrophage colony stimulating factor (MCSF), granulocyte macrophage colony stimulating factor (GM-CSF), interleukin-1-beta
(IL-1β), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1) [22, 23].
These have each been shown to be present at times of inflammation, specifically
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associated with orthopedic implants. Chemokines are a final category of cytokines
present and relevant in the loosening of THA devices. These function in attracting white
blood cells to sites of infection. The well-known chemokines found in literature to be
relevant in metal orthopedic implants with loosening are interleukin-8 (IL-8),
macrophage inflammatory protein-1-alpha (MIP-1α), eotaxin, and macrophage
inflammatory protein-3-alpha (MIP-3α) [24].
Each of these classes of cytokines play a role in the inflammation and potentially
result in aseptic loosening, which is why the concentrations of each of these will be
measured in the synovial fluid of each retrieved device. The kits used for the
inflammatory cytokine testing were purchased from R&D Systems (Minneapolis, MN).
The kits purchased allowed us to test for TNF- α, M-CSF, IL-1 β, IL-6, CCL2/MCP-1,
IL-2, CXCL8/IL-8, and MIP-3 α. These eight cytokines were targeted because they are
known to play a role in the inflammatory process. TNF-α and IL-1β were the first
cytokines shown to stimulate bone resorption in vitro, so these cytokines were identified
early as cytokines of interest when studying total joint replacements. One study compared
the synovial levels of TNF-α and IL-1β in patients with loosened prostheses, fixed
prostheses, and osteoarthritis controls [25]. A difference was found in these levels
between loosened and osteoarthritis groups, but not loosened and fixed implants. IL-6
and IL-8 were selected because of their roles in the inflammatory process as well. IL-6 is
secreted by osteoblasts to induce osteoclast formation and can act as either a proinflammatory or anti-inflammatory cytokine. IL-8 is a chemokine released by periimplant cells such as macrophages, epithelial cells, mesenchymal stem cells, mast cells,
and endothelial cells. Lassus et al. reported elevated levels of IL-8 in the pseudocapsular
tissue and synovial-like interface membrane in loosened THAs compared to controls
[26]. Clarke et al. found statistically significant increases in the levels of IL-1β, IL-6, and
IL-8 in synovial fluid from TJRs requiring revision due to aseptic loosening compared to
patients undergoing primary TJR for OA [27]. IL-6 has also been identified as a potential
biomarker in periprosthetic joint infection. One study noted significantly elevated levels
of serum IL-6 in infected prosthetic joints when compared to aseptic joints undergoing
revision surgery [28]. MCP-1 and MIP-3α have been identified as chemokines that are
involved in the implant aseptic loosening pathology. Nakashima et al. observed MCP-1
and MIP-3𝛼 expression in all tissue samples from failed arthroplasties, establishing their
presence in the inflammatory cascade of arthroplasty failure [29]. They were also able to
induce expression of MCP-1 by macrophages in cell culture after exposure to different
types of wear particles. Because of the results identified in these studies, these eight
cytokines were selected as cytokines of interest in the inflammatory process that may
contribute to implant complications such as infection or aseptic loosening.
Metal Ion Concentrations
Levels of cobalt, chromium, molybdenum, and titanium ions in the blood are
frequently used as an indication of if there are metal components of an implant
articulating against one another and causing pain and potentially other systemic problems
in patients with a THA. In a study done by Savarino et al, cobalt, chromium, and
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molybdenum ion levels were measured in patients in four groups: those with a metal on
metal bearing, those with a metal on polyethylene bearing, those with osteoarthritis
before implantation of a THA, and those with no systemic problems [30]. The values
seen for cobalt levels in each of these groups, respectively, were 1.33 ng/ml, 0.64 ng/ml,
0.36 ng/ml, and 0.24 ng/ml. For chromium, the values were 1.72 ng/ml, 0.60 ng/ml, 0.26
ng/ml, and 0.25 ng/ml. Finally, for molybdenum, these values were 0.62 ng/ml, 0.62
ng/ml, 0.42 ng/ml, and below detection limits for the group with no pathology. These
values were consistent with other findings in literature. The same ions were tested for in
this study and were compared to these values. In this study, the samples were analyzed at
Brooks Applied Labs (Bothel, WA) and the results were sent in micrograms per liter
(µg/L).
Toxicology of Metal Ions
As mentioned previously, the ions of interest when studying orthopedic implants
are mainly cobalt, chromium, and molybdenum, each of which have the capacity of affect
the body in different ways. Cobalt has been shown to be cytotoxic and induce apoptosis
at lower doses, and cause necrosis with an inflammatory response at higher doses in
mammalian in vitro test systems. It is primarily accumulated in the liver, kidney,
pancreas, and heart. The excretion of cobalt is initially rapid through the renal system
over the first few days, but then slows and leads to significant long-term retention in the
tissues for several years. In serum, the cobalt ions bind to binding sites on albumin, so
therefore, the concentration of free cobalt ions is estimated to be only 5-12 percent of the
total cobalt concentration in the body [31]. Because cobalt ions can bind to albumin, it
can affect how it is distributed in the body. If the albumin concentrations in the body are
low, less cobalt ions are able to bind to the binding sites on the albumin, leaving these
cobalt ions free to interact with specific protein carriers with other cellular targets. These
free cobalt ions can cause cobalt ion buildup in other tissues [32]. Studies have shown
chromium to be cytotoxic as well, especially hexavalent chromium, which is considered
grossly cytotoxic. Chromium can cause inhibited osteoblast-like cell metabolism, reduced
phagocytic ability of polymorphonuclear leukocytes and murine macrophages, and can
increase release of inflammatory mediators and cell death in macrophages. It has also
been found that if more toxic elements such as chromium are selectively leached, this can
lead to an increase in the toxicity of degradation products from the cobalt-chromiummolybdenum alloy [33]. Additionally, in a study to observe how metal ions affect bone
marrow stromal cells, chromium ions were found to be grossly cytotoxic, while cobalt,
molybdenum, iron, and nickel ions were found to be moderately cytotoxic, and titanium,
aluminum, vanadium, and manganese ions were found to be minimally cytotoxic [34].
There has been less research done on molybdenum’s cytotoxicity, however, one study
that tested particles of pure metals in a mouse fibroblast cell line. While they found toxic
effects of cobalt and chromium at several levels, toxicity of molybdenum was only seen
at the highest concentration tested, 500 micrograms per milliliter [35].
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Objective and Hypothesis
While total hip arthroplasty is one of the most common orthopaedic procedures
performed today, there are very few implant retrieval studies being performed to assess
these implants after implantation. Of the implant retrieval studies in existence, most are
of failed implants retrieved at time of revision surgery, and very few are of wellfunctioning implants at time of necropsy. The objective of this work was to study a few
key factors such as taper dissociation force, polyethylene wear, taper corrosion,
inflammatory cytokine content in synovial fluid, and metal ion content in the tissue to see
if any of these factors may be indicative of implant survivorship. Another objective was
to compare these parameters to one another and see what relationship existed between
them, if any. A final objective is to use these as “baseline values” when completing the
same tests on a group of failed implants in the future. To this end, the following
hypotheses were tested:
(a)

A negative relationship will exist between dissociation force and cytokine
concentration. A higher dissociation force means that the taper connection is more
intact, therefore, there is less corrosion and material loss in the taper connection
and therefore less of an inflammatory response due to debris. However, it should
be noted that cytokine concentrations are affected not only by metallic debris, but
also by polyethylene debris, so an increase in cytokine concentrations could be
due to either type of debris. Nonetheless, a negative association between
dissociation force and cytokine concentration is expected in this study.

(b)

A negative relationship will exist between dissociation force and corrosion. The
tapers that are more highly-corroded will likely be experiencing more material
loss on the trunnion and bore, and therefore, will have a lower dissociation force.
The implants with less corrosion (minimal to mild) should have higher
dissociation forces than those with more corrosion (moderate to severe), and the
contacting surfaces have less corrosion and therefore material loss.

(c)

A negative relationship will exist between metal ion content and dissociation
force. As mentioned previously, a higher dissociation force means the taper
connection is more intact, so there should be less corrosion and material loss at
this site. Therefore, if there is less material being lost, the metal ion content will
be lower.

(d)

A positive relationship will exist between polyethylene wear and cytokine
concentration. As the femoral head articulates against the polyethylene liner,
debris are generated. In order to combat these debris, macrophages attempt to
engulf the particles and often secrete inflammatory cytokines as a response.
Therefore, a higher amount of wear on the polyethylene liner should result in a
higher concentration of inflammatory cytokines.

(e)

A positive relationship will exist between metal ion content and cytokine
concentrations, specifically cobalt and titanium ion content. Similar to the
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polyethylene and cytokine comparison, if there is more metal debris in the tissue,
inflammatory cytokines will be released as macrophages are recruited to manage
this debris. Cobalt has been found to increase IL-6 from osteoblast like cells[36,
37]. Cobalt ions have also been shown to rapidly induced the protein secretion of
IL-8 and MCP-1 in primary human osteoblasts[38]. Titanium has been shown to
induce the differentiation of osteoclast precursors toward mature osteoclasts in
about twenty percent of individuals[39]. While cobalt and titanium have been
shown to increase cytokine activity, there have been no studies demonstrating this
same phenomenon with chromium ion. Therefore, it is likely that no relationship
will exist between chromium ion content and cytokine concentrations.
(f)

Higher metal ion content will be seen in implants with higher corrosion due to
material loss as mechanically assisted crevice corrosion occurs. Therefore, the
implants with higher corrosion scores (moderate, severe) will have an increased
concentration of metal ions compared to the implants with lower corrosion scores
(minimal, mild).
Equipment Used

Instron 4505 Load Frame
An Instron 4505 Load Frame (Instron, Norwood, MA) was used for the
mechanical head dissociation testing. This allows the stem of the implant to be pulled
from the head of the implant at a precise rate and the resulting force to be measured. A
custom mechanical test frame was created for this testing in the Implant Research Center
at Drexel University (Philadelphia, PA), where the testing was completed (Figure 1-7).
Fluoroscopy
Fluoroscopy was used prior to implant retrievals in order to assess the fixation of
the implant, check for osteolysis, or bone loss around the implant surface thus verifying it
is in fact a well-functioning implant, and to see if there were any screws or other parts in
place to be aware of before beginning retrieval. The model used was the OrthoScan HD
Model 1000-0001 (OrthoScan, Scottsdale, AZ).
Calibrated Micrometer
A calibrated digital micrometer was used for linear polyethylene wear
measurements. One side of the micrometer was placed on the back of the polyethylene
and the other side was placed on the front in order to determine thickness at a particular
location. The micrometer used is a Mitotoyo Digimatic Micrometer Series 293 MDC-MX
Lite and measures to 0.001 millimeters (Mitotoyo, Aurora, IL).
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Figure 1-7.

Custom test frame for head dissociation testing, Drexel University

(Personal communication from Genymphas Higgs on May 16, 2016)
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Luminex Multiplexer
Multiplex assays were performed using the Luminex system. This platform
enables simultaneous measurement of multiple proteins per well on a ninety-six well
plate using very little sample (approximately thirty microliters per sample). This
technology produces results comparable to ELISA assays but with higher efficiency and
speed. It is also less expensive per target than ELISA. The multiplexer used was the
Luminex MAGPIX (Luminex Corporation, Austin, TX).
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CHAPTER 2.

METHODOLOGY

Retrieval Methods
The total hip implants used in this study came from one of two sources: the
Medical Education and Research Institute (Memphis, TN) or RestoreLifeUSA
(Elizabethton, TN). Cadaver specimens of the hip and proximal femur were obtained
from both institutes, and were frozen until retrieval could take place. Before retrieval,
images were taken using fluoroscopy to see if there was any obvious osteolysis. During
the retrieval, incisions were made in order to expose the tissue surrounding the bone
where the implant was located. Tissue samples were obtained anterior, posterior, inferior,
and superior to the acetabular cup, as well as from the taper itself. The tissue-implant
interface was assessed as recommended by ASTM Standard F561-13. Figure 2-1 shows
pictorially where the samples were obtained. Synovial fluid samples were aspirated from
the joint and centrifuged at 1600 rpm for twenty minutes to remove cell particles, then
kept frozen in a -80 degrees Celsius freezer. The implant was then removed from the
bone as recommended by ASTM Standard F561-13, placed in biohazard bags, and
shipped to Drexel University (Philadelphia, PA) for cleaning, wear scoring, and
mechanical testing [40].
Implant Cleaning
The implants were cleaned using a method designed by Drexel University Implant
Research Center in accordance with ASTM Standard F561-13 [40]. The implants were
removed from packaging and biohazard bags and examined to ensure all parts were
present. Inventory pictures were taken of the bag and all implant components, ensuring
the implant number was visible. Each component was rinsed in cold water in a biohazard
sink in order to remove any loose tissue. A 1:10 Discide:water solution was mixed in a
mixing cup and the implants were placed in the solution for a twenty minute soak.
Brushes were then used to remove remaining tissue from the implant while being careful
not to scratch or damage the implant surface in any way. The Discide:water solution was
then disposed of and a 1:10 bleach:water solution was created. The implants then
completed another 20 minute soak, and brushes were again used to remove loose debris.
At this point, the implant components were no longer considered biohazard and could be
placed in a clean mixing cup. For ceramic components, the cleaning process ended here.
If the components were metallic, they were placed in a clean mixing cup and the
cup was filled with water. These cups were then placed in an ultrasonicator for 25
minutes, keeping the water level in the ultrasonicator the same as the water level in the
mixing cups. The mixing cups and implants were then removed from the ultrasonicator,
the water was drained and the cups were refilled and placed back in the ultrasonicator for
another 25 minutes. The implants were then laid out on Versidry sheets overnight to air
dry within the fume hood. The implants were then packaged in separate bags to avoid
scratching one another and labeled to await testing and wear scoring.
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Figure 2-1.

Tissue sample locations

Modified with permission.

Foran, J.R.H. Total Hip Replacement. OrthoInfo 2015 8/2015 [cited 2016 8/18/16].
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Head Dissociation Testing
This testing was completed in accordance with ASTM Standard F2009-00,
discussed previously. An Instron 4505 was used for the entirety of this testing procedure,
following a Standard Operating Procedures document created by Drexel University. Load
frame verification should be performed before any testing to ensure all components are
working properly. A custom testing frame (Drexel University) was used for this testing to
allow the head to be separated from the stem of the implant. This frame included
specially designed head and stem plates that allowed the taper to be oriented vertically for
the entirety of the testing. Before testing began, a 30 kN load cell was installed in the
Instron, and calibration and balance of the load cell was completed on the Instron
machine.
After calibration and balance was completed, the custom femoral stem and head
fixtures were assembled into the crosshead of the Instron. The specimen was placed in
the head fixture with the stem hanging downward. The crosshead was then raised until
the stem entered the stem fixture. The crosshead was then raised slowly until there was
only enough space between the head fixture and stem fixture for attachment of the stem
plate. The load channel was set to zero to create a unique set point for each test sample,
as samples masses may vary. The stem plate was then connected to the fixture using four
bolts, ensuring no preload was exerted on the implant, and the crosshead was slowly
lowered until the sample was oriented with the taper connection vertical. A small gap was
left between the connection and stem plate to allow for a toe region in the data and to
ensure no preload was present. The Instron then began moving the stem fixture down,
away from the head fixture, at 0.05 mm/s, recording the resulting force continually.
When the load suddenly dropped, the Instron recognized that the connection between the
stem and head was broken and stopped displacement. The peak load was recorded as the
force needed to dissociate the head and stem.
Corrosion Scoring
For head corrosion scoring, a Goldberg Corrosion Classification was used [41].
The components of the implants were cleaned to ensure the damage that was seen was
damage to the implant itself and not residue of any kind. Three scorers examined the
implant components under a microscope and independently viewed the male and female
taper components and scored them from 1 to 4, following the criteria shown in Table 2-1
and looking for all signs of fretting or corrosive attacks. After each scorer had completed
scoring of both components, the scorers reviewed the results together and discussed any
discrepancies. The components with discrepancies were studied under microscopy again,
and a final score was agreed upon by all three scorers.
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Table 2-1.

Criteria for taper corrosion scoring

Damage
Minimal

Score
1

Mild

2

Moderate

3

Severe

4

Criteria
Fretting on < 10% of surface and no
corrosion damage
Fretting on > 10% of surface and/or
corrosion attack confined to one or
more small areas
Fretting > 30% and/or aggressive
local corrosion attack with corrosion
debris
Damage over majority (> 50%) of
mating surface with severe corrosion
attack and abundant corrosion debris
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Metal Ion Testing
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is an analytical
technique used to make elemental determinations of a material. This method combines
high-temperature ICP with a mass spectrometer. The ICP source converts the atoms of
the elements in the associated sample to ions, which are then separated and able to be
detected by a mass spectrometer. For this testing, tissue samples were taken from two
locations: anterior and posterior to the acetabular cup. These samples were placed in
fixative and sent to Drexel University for sample preparation and analysis.
To prepare for the acid digestion of the tissue samples, the laboratory space and
equipment was prepared by rinsing and soaking all tools in an acid solution consisting of
five to ten percent trace metal nitric acid and eighteen mega-ohm ultrapure water
overnight. This process included sample containers, the digest vessel, and any other
equipment that would be in direct contact with the samples. Any minor tools involved in
the process were washed twice and dried with Kimtech wipes. Once the laboratory space
and equipment were prepared, the samples were cut to a 25 milligram size using a
ceramic knife and plastic tweezers. Care was taken to ensure the samples did not contact
any form of metal. A water bath was set to ninety-five degrees Celsius, and centrifuge
tubes were labeled to identify the samples. The samples were then washed with eighteen
mega-ohm ultrapure water to remove ethanol, and were placed in the correctly labeled
tube. The acid solution was created by adding two milliliters of seventy percent trace
metal grade nitric acid to each tube under a fume hood. Next, one milliliter of hydrogen
peroxide was added to each tube followed by three milliliters of thirty-seven percent trace
metal grade hydrochloric acid, also under the fume hood. Three samples of only acid
solution were also prepared in three tubes with no tissue samples as blank samples. The
hydrogen peroxide was allowed to react as the water bath heated to the correct
temperature. Once heated, the tubes were placed in the water bath for a two-hour
incubation period. After the two-hour period, the tubes were removed and placed in the
fume hood for thirty minutes to cool. After the cooling period, an addition one milliliter
of hydrogen peroxide was added to each tube and given thirty minutes to react. The tubes
were then placed back into the water bath for an additional two-to-three-hour incubation
period.
The samples were then placed into labeled two milliliter micro-centrifuge tubes to
be sent to Brooks Applied Labs (Bothell, WA). Each tube received one milliliter of the
sample and acid mixture and one milliliter of eighteen mega-ohm ultrapure water. The
remaining sample was diluted to a fifteen milliliter volume with the eighteen mega-ohm
ultrapure water. The method for analysis used by Brooks Applied Labs was validated
using the Luts-1 certified reference material from the National Research Council of
Canada. This material is a solid biological matrix that contains certified quantities of
cobalt and chromium.
Once Brooks Applied Labs completes the analysis, the data was first checked to
ensure the blank samples had low levels of metal. Any amount of metal in the blank
sample was considered to be a contamination. If the contaminants were low in value and
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consistent between the blanks, they were averaged and the average was subtracted from
the remaining samples. This allows the final data to be represented without the
background noise present due to uncontrollable contamination. The data was then
reported in either micrograms per liter or parts per billion.
Polyethylene Degradation
A Standard Operating Procedure from Drexel University was used for these
measurements. The polyethylene liners were removed from the acetabular cups and
rinsed to remove any debris present. Next, these liners were studied under a microscope
to see if any machining lines could be seen. A marker was used to draw a border of where
machining lines were present, and where they tended to be worn down. The area where
the machining lines were worn was considered to be the superior side. A few
measurements were taken using a Mitotoyo Digimatic Micrometer Series 293 MDC-MX
Lite (Mitotoyo, Aurora, IL) to determine the thinnest area of the liner. This was marked
with an “S” for superior and the opposite was marked with an “I” for inferior. Three
measurements were taken from the superior side halfway up the polyethylene liner, and
three measurements were taken from the inferior side, ensuring they were also made at
the halfway point of the liner. These three measurements were averaged and the superior
measurements were subtracted from the inferior, giving the total polyethylene linear
wear. Although this measurement was called the wear, it should be noted that some of the
decrease in thickness of the superior side could be due to creep, or deformation of the
material due to high stresses. Unfortunately, this was not something that could
necessarily be directly calculated so it was a noted area of weakness in our measurement.
Inflammatory Cytokine Testing
The cadaveric cytokine samples were tested using the Luminex Multiplex Assay.
A group of sixteen osteoarthritic samples were obtained with IRB approval from patients
undergoing primary total hip arthroplasty to use as a comparison to the fourteen
cadaveric samples. For the assay, the standards, calibrator diluent RD6-52, samples, and
diluent RD2-1 were brought to room temperature. The Certificate of Analysis provided
with the kit was followed in order to reconstitute each standard cocktail with RD6-52
diluent. These were left under gentle agitation for 15 minutes prior to making dilutions.
The RD6-52 diluent was used to dilute each sample by 2, using 80 microliters (µL) of
sample and 80 µL of diluent, giving 160 µl of diluted sample in each tube. The standard
cocktails were created according to directions in the booklet to create standards 1-6. The
lights were turned off, and the microparticle cocktail was centrifuged for 30 seconds at
1000 G. The cocktails were gently vortexed and then diluted with RD2-1. The standards
and samples were then added to their corresponding wells and covered with a foil sealer,
and incubated for two hours at room temperature on a microplate shaker. During this
time, the wash buffer was created by adding 20 milliliters (mL) wash buffer concentrate
to 480 mL deionized water. With the lights still off, a magnet was placed on the bottom
of the microplate and the plate was shaken over sink to remove liquid. Each well was
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filled with 100 µL of wash buffer which was then shaken out, and this was repeated two
more times. The biotin antibody cocktail was then centrifuged and diluted with RD2-1.
Each well received 50 µL of the diluted biotin cocktail and was incubated for 1 hour at
800 rotations per minute (rpm) under a foil plate sealer. The streptavinin cocktail was
then created by mixing 220 µL with 5.35 mL of wash buffer. The wells were washed
with wash buffer three times, and then 50 µL of the streptavinin cocktail was added to
each well. This was incubated for 30 minutes at room temperature at 800 rpm. The wells
were then washed three times with wash buffer again. Finally, 100 µL of wash buffer was
added to each well and incubated for two minutes at 800 rpm, and the plate was read on
the magpix reader, with concentrations given in picograms per milliliter (pg/mL).
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CHAPTER 3.

RESULTS

Implant Information
There were a total of nineteen implants retrieved for this testing, but not all of the
implants were able to undergo each type of testing, and the full implant information was
not able to be obtained for all implants. In these nineteen implants, there were five with
28 mm heads, five with 32 mm heads, four with 36 mm heads, and two with 40 mm
heads. Fourteen of the acetabular liners were highly crosslinked polyethylene, and four
were not highly crosslinked. Of the metal on polyethylene implants, nine had a cobalt
chromium alloy head on a titanium alloy stem, and four had a cobalt chromium alloy
head and stem. Two implants were ceramic heads on a titanium alloy stem. One of these
heads was zirconia and the other was a zirconia alumina combination. Eight of the
implants had a head taper angle of 12/14 and one had an angle of 16/18. None of the
implants had cemented shells, and two had cemented stems. The manufacturer, design,
and other implant characteristics can be seen in Table 3-1.
Head Dissociation Testing
The dissociation forces in this study ranged from 1428 to 5368 Newtons, with a
mean and standard deviation of 2790±1200 Newtons. The sample size for this testing was
15 implants, with two of these having ceramic heads (16-03-730R and RLU0519169R).
These results can be seen in Figure 3-1.
Corrosion Scoring
As mentioned previously, the male and female tapers were each scored from 1 to
4 based on the Goldberg Corrosion Classification. The scores for each portion of these
implants can be seen in Table 3-2.
Inflammatory Cytokine Testing
For the group of sixteen osteoarthritis control samples, eight cytokines were
tested. They were IL-6, MCP-1, IL-1β, MIP-3α, M-CSF, IL-8, IL-2, and TNF-α. The
values for IL-8, MCP-1, MIP-3α, and M-CSF were mostly in range for each sample, but
most were very close to the lower limit of detection so were obviously not very active in
the body. For TNF-α, only six of the sixteen samples were in the detectable range, and
these samples were just above the lower limit of detection. For IL-6, seven of the sixteen
samples were in the detectable range, with the other nine samples being above the limits
of detection. For IL-2, nine of the sixteen samples were in the detectable range, with the
other seven being below the lower limit of detection. For IL-1β, all sixteen samples were
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Table 3-1.

Femoral component information

Sample ID

Design

14-11-788R
16-03-730L
14-08-614L

Duraloc
Trilogy
Reflection

14-08-580L

Reflection

14-05-425L
16-03-730R

Trilogy
Richard
Reflection
Trident
Pinnacle
Trilogy
Pinnacle
Trilogy
Trilogy
Continuum
Ringloc
Constrained
Pinnacle
Richard
Reflection
Trilogy

16-08-983R
RLU1114149R
RLU0315169 L
15-10-288L
RLU0519169L
15-10-491R
14-12-835L
15-08-338L
15-10-466L
RLU1029149R
14-12-835R
RLU0519169R

Trident

Manufacturer

Head
Material

Head
Size
(mm)
28
32
--

Taper
Angle

HXLPE

Stem
Material

-12/14
--

N
Y
Y

-Ti6Al4V
--

--

--

--

Y

--

Depuy
Zimmer
Smith and
Nephew
Smith and
Nephew
Zimmer
Smith and
Nephew
Stryker
Depuy
Zimmer
Depuy
Zimmer
Zimmer
Zimmer
Biomet

CoCrMo
CoCrMo
CoCrMo

Metal
White
Zirconia
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo

32
28

12/14
--

Y
N

Ti6Al4V
Ti6Al4V

36
40
28
36
36
36
32
--

12/14
12/14
12/14
-12/14
12/14
--

Y
Y
Y
Y
Y
Y
Y
--

Ti6Al4V
Ti6Al4V
CoCrMo
CoCrMo
Ti6Al4V
CoCr
Ti6Al4V
Ti6Al4V

Depuy
Smith and
Nephew
Zimmer

CoCrMo
CoCrMo

32
28

---

Y
N

CoCrMo
Ti6Al4V

CoCrMo

32

12/14

Y

Stryker

ZirconiaToughened
Alumina

40

16/18

Y

Ti6Al4V /
TA
Ti6Al4V
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Dissociation Force (N)

6000
5000
4000
3000
2000
1000
0

Sample ID

Figure 3-1.

Graph of the dissociation force for each tested implant

Table 3-2.

Corrosion scores for male and female taper components

Sample ID
14-08-614L
16-03-730R
15-10-491R
RLU1114149C R
15-10-466L
RLU0315169B L
14-12-835R
14-12-835L
15-10-288L
14-08-580L
RLU1029149C
14-05-425L
16-08-983R
RLU0519169L
RLU0519169R

Corrosion Score
Female
2
Ceramic
1
2
2
2
1
2
1
2
1
2
1
1
Ceramic
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Male
1
1
1
1
1
3
1
1
1
1
1
1
1
1
1

below the limits of detection. The cytokine concentrations for each sample can be seen in
Table 3-3.
For the group of fourteen cadaveric implants, the same eight cytokines were
tested, but there were only five main cytokines of interest. These were IL-6, MCP-1, IL1β, MIP-3α, and M-CSF. The cytokine results for IL-8 were above the detection limits
for nine out of the fourteen samples tested, meaning that there is likely IL-8 present in
high amounts, though it is not quantifiable. For TNF-α, only five of the fourteen samples
were in range, with the rest falling below the limits of detection. The five that were in
range were very close to the lower limit of detection, making them essentially irrelevant.
For IL-2, only four of the fourteen samples tested were in range, the rest falling below the
limits of detection. Similarly to TNF-α, even the samples from these four samples that
were in range were very close to the lower limit of detection. The cytokine concentrations
for each sample can be seen in Table 3-4.
Mann Whitney tests were done between the two groups for each cytokine, and
significant differences were seen between the groups for IL-8 (p <0.001), IL-1β
(p<0.001), IL-1 (p=0.002), and M-CSF (p<0.001). However, this could be due to the fact
that many of the values were on the very low end of detection for these groups, with one
sample being elevated which could cause the differences to be seen.
Linear Polyethylene Wear Measurements
Values for polyethylene wear measurements ranged from 0.040 to 1.867
millimeters (mm). However, the value of 1.867 mm was found to be an outlier. The mean
and standard deviation were 0.296±0.468 mm including this outlier, but decreased to
0.184±0.215 mm excluding the outlier. These values can be seen in Table 3-5.
ICP-MS
The samples were analyzed by Brooks Applied Labs (Bothell, WA) and results
for cobalt, chromium, and titanium levels were obtained from the anterior and posterior
tissue capsule in micrograms per liter (µg/L). These were averaged and are reported in
Table 3-6 for every implant except 16-08-983R, as tissue samples were not obtained for
this components. This table also includes the head and stem material for the implants to
help interpret these results.
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Table 3-3.
Concentrations of inflammatory cytokines for osteoarthritis control
specimens (pg/mL)
Sample ID

IL-6

MCP-1

IL-1B

002

>1180

350.84

<16.3

MIP3a
11.64

563.13

TNFα
<8.9

003

17.73

232.96

<16.3

8.85

<514

<8.9

004

804.15

391.40

<16.3

10.70

1104.00

005

>1180

250.69

<16.3

13.56

006

44.60

342.23

<16.3

007

16.22

455.35

<16.3

008

>1180

1613.10

009

>1180

M-CSF

IL-8

IL-2

8.53

35.86

6.80

<35

<8.9

12.78

<35

1168.03

<8.9

11.18

<35

<7.9

742.55

<8.9

11.24

<35

9.77

1042.74

9.93

19.77

<35

<16.3

20.79

1050.52

9.43

137.66

47.89

720.25

<16.3

14.04

1698.83

<8.9

58.71

37.24

010

88.60

515.90

<16.3

44.08

1184.25

9.43

25.34

<35

011

>1180

3210.13

<16.3

47.26

1018.99

9.18

>1140

43.48

012

>1180

1254.41

<16.3

45.43

673.61

9.56

56.51

36.55

013

>1180

923.25

<16.3

20.04

1578.72

<8.9

191.22

40.01

014

174.07

389.67

<16.3

9.76

6050.69

<8.9

14.39

<35

015

>1180

758.41

<16.3

14.55

<514

<8.9

33.72

36.55

016

>1180

819.11

<16.3

12.61

703.08

<8.9

26.71

36.78

017

1164.60

1605.89

<16.3

37.93

1234.53

<8.9

244.69

46.03

Mean

808.12

864.60

<16.3

21.40

1415.26

9.37

124.95

40.04

St. Dev.

524.48

768.205

-

14.42

1372.90

0.42

279.93

4.60

32

Table 3-4.
(pg/mL)

Concentrations of inflammatory cytokines for cadaveric specimens

3724.40

MIP3a
11.73

IL-8

IL-2

73237.05

TNFα
<8.9

20.16

9.55

>1140

<35

51918.99

<8.9

>1140

<35

2177.16

53.18

15.34

46051.50

<8.9

>1140

35.64

271.68

143.90

14.22

54057.49

9.78

>1140

<35

>1180
27.77

>7940

485.56

>1920

32312.03

16.05

>1140

76.29

113.35

129.72

<7.9

52170.45

<8.9

284.82

<35

15-08-338L

885.25

4243.78

45.43

122.22

33171.82

<8.9

>1140

<35

RLU0315169B L

20.18

411.68

178.07

28.96

14963.88

<8.9

694.16

<35

14-12-835R

91.31

286.65

70.96

8.53

62937.91

<8.9

>1140

<35

14-12-835L

87.13

414.07

115.95

18.69

69956.68

<8.9

>1140

<35

15-10-288L

>1180

649.77

128.98

100.84

77613.82

9.78

>1140

<35

RLU0519169L

102.86

489.24

63.06

20.55

34835.14

9.43

>1140

<35

Sample ID

IL-6

MCP-1

IL-1B

14-08-614L
16-03-730L

702.97

<98

829.69

511.02

16-03-730R

735.44

15-10-491R

81.66

RLU1114149C R
15-10-466L

M-CSF

RLU0519169R

93.87

409.96

51.12

23.90

54334.86

8.93

>1140

<35

Mean

433.71

1292.27

376.67

164.51

52054.13

<8.9

977.70

<35

St. Dev.

456.11

2219.31

970.36

506.54

18336.89

-

340.18

-

Table 3-5.

Linear polyethylene wear measurements for each sample (mm)

Sample ID
14-08-614L
16-03-730L
16-03-730R
15-10-491R
RLU1114149C R
15-10-466L
RLU0315169B L
14-12-835R
15-10-288L
14-08-580L
RLU1029149C
14-05-425L
16-08-983R
RLU0519169L
RLU0519169R

Polyethylene Linear
Wear (mm)
0.040
0.151
1.867
0.224
0.097
0.099
0.086
0.087
0.351
0.089
0.909
0.111
0.071
0.131
0.126
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Table 3-6.
Cobalt, chromium, and titanium levels for implant (ppb or µg/L) and
component material for each
Sample ID
14-08-614L
16-03-730L
16-03-730R
15-10-491R
RLU1114149C
R
15-10-466L
15-08-338L
RLU0315169B
L
14-12-835R
14-12-835L
15-10-288L
14-08-580L
RLU1029149C
14-05-425L
14-11-788R
16-08-983R
RLU0519169L
RLU0519169R
Mean
St. Dev.

Cobalt
(ppb)
0.2875
0.8030
2.3013
1.3335

Chromium
(ppb)
3.3730
8.0955
5.2407
1.2918

Titanium
(ppb)
0.0000
0.7548
0.0000
0.0000

Stem
Material
CoCr
CoCr
Zirconia
CoCr

Head
Material
Ti
Ti
CoCr

4.4546
0.5363
3.8725

51.2542
24.5765
4.8174

1.9681
21.2185
0.0000

CoCr
CoCr
CoCr

Ti
CoCr
Ti

1.1816
0.3901
2.2751
3.6876
0.5759
0.7221
7.8357
576.0150
2.0000
0.2637
35.7962
139.2254

1.4999
1.9043
44.4078
32.4262
10.4695
1.4135
29.7613
1960.2175
185.5829
4.4603
139.4584
471.2798

0.0000
269.5773
3.0290
0.0000
2.2960
33.7643
0.0000
142.6086
13.1055
1.9699
28.8407
70.9989

CoCr
CoCr
CoCr
CoCr
CoCr
Metal
CoCr
CoCr
CoCr
Alumina
-

CoCr
Ti
Ti
CoCr
Ti
Ti
Ti
Ti
Ti
Ti
-
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Testing Comparisons
Dissociation Force versus Cytokine Concentrations (a)
The concentrations of each of the relevant inflammatory cytokines were compared
to the dissociation forces for each sample. Cytokine levels that were below the limits of
detection were not included in these comparisons, however, those that were above the
limits of detection were included, with their value being the maximum detectable limit.
Direct comparisons were done between the two variables and a linear trendline was
applied to determine how significant this correlation was. However, since no one in
literature has used any specific trend to assign to this type of data, the variables were also
ranked (one rank for dissociation force and one rank for cytokine concentrations) for each
sample, and those ranks were plotted against one another to determine if there was any
significance in these comparisons. The direct comparison and the ranked comparison for
the five relevant inflammatory cytokines can be seen in Figures 3-2 through 3-11. The
correlation coefficients, confidence interval for the correlation, and Pearson’s rank pvalues for each comparison can be seen in Tables 3-7 and 3-8, and the correlation
coefficients and Pearson rank p-values once outliers were removed can be seen in Tables
3-9 and 3-10.
Dissociation Force versus Head Corrosion Scores (b)
The stem components of the implants, as shown previously in Table 3-1, were
almost all given a score of 1 with one exception, being scored a 3. However, the head
scores were fairly equally distributed between 1 and 2. Therefore, these were separated
into two groups based on corrosion scores, and normality was assessed with a ShapiroWilk test. The two groups were found to be normally distributed with equal variances, so
a t-test was performed to see if there was a difference in dissociation force between the
two groups. The p-value for this t-test was 0.6 with a power of 8%, meaning that while no
significant difference could be detected, a low power makes us less likely to detect a
difference when one does in fact exist.
Dissociation Force versus Metal Ion Concentrations (c)
The dissociation force of each implant was compared to the cobalt, chromium,
and titanium levels for each implant. There were eleven total samples for which
dissociation forces as well as metal ion concentrations were able to be obtained. Direct
comparisons were done between the two variables and a linear trend line was applied to
assess the significance of the relationship. However, since nothing was found in literature
applying any specific trend to assess this type of data, the variables were also ranked (one
rank for the dissociation force and one rank for the metal ion levels) for each sample, and
those ranks were plotted against each other to determine if there was any significance in
these comparisons. The direct comparison and ranked comparison for each of the three
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Figure 3-2.

IL-6 concentration compared to the dissociation force
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Figure 3-3.

IL-6 rank among all samples compared to the dissociation force rank
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Figure 3-4.

MCP-1 concentration compared to the dissociation force
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Figure 3-5.
rank

MCP-1 rank among all samples compared to the dissociation force
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Figure 3-6.

IL-1β concentration compared to the dissociation force
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Figure 3-7.

IL-1β rank among all samples compared to the dissociation force rank
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Figure 3-8.

MIP-3α concentration compared to the dissociation force
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Figure 3-9.
rank

MIP-3α rank among all samples compared to the dissociation force
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Figure 3-10. M-CSF concentration compared to the dissociation force
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Figure 3-11. M-CSF rank among all samples compared to the dissociation force
rank
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Table 3-7.
Correlation coefficients and p-values for the direct comparison of
each cytokine to its dissociation force
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
12
10
12
10
12

Correlation
Coefficient (r)
0.32
0.64
-.066
0.67
-0.37

95% Confidence
Interval of r
-0.32 to 0.75
0.01 to 0.90
-0.62 to 0.53
0.069 to 0.91
-0.78 to 0.26

P-Value
0.3
0.05
0.8
0.03
0.2

Table 3-8.
Correlation coefficients and p-values for the ranked comparison of
each cytokine to its dissociation force
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
12
10
12
10
12

Correlation
Coefficient (r)
0.44
0.30
0.23
0.22
-0.26

95% Confidence
Interval of r
-0.19 to 0.81
-0.41 to 0.78
-0.40 to 0.71
-0.47 to 0.75
-0.73 to 0.37

P-Value
0.2
0.4
0.5
0.5
0.4

Table 3-9.
Correlation coefficients and p-values for the direct comparison of
each cytokine to its dissociation force with outliers removed
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
12
8
10
10
12

Correlation
Coefficient (r)
0.32
0.041
-0.14
0.014
-0.37
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95% Confidence
Interval of r
-0.32 to 0.75
-0.68 to 0.72
-0.71 to 0.54
-0.62 to 0.64
-0.78 to 0.26

P-Value
0.3
0.9
0.7
0.9
0.2

Table 3-10. Correlation coefficients and p-values for the ranked comparison of
each cytokine to its dissociation force with outliers removed
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
12
8
10
10
12

Correlation
Coefficient (r)
0.44
0.050
0.069
-0.16
-0.26
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95% Confidence
Interval of r
-0.19 to 0.81
-0.68 to 0.73
-0.59 to 0.67
-0.72 to 0.52
-0.73 to 0.37

P-Value
0.2
0.9
0.9
0.7
0.4

metal ions assessed can be seen in Figures 3-12 through 3-17. The correlation
coefficients, confidence interval for the correlations, and Pearson rank p-values for each
comparison can be seen in Tables 3-11 and 3-12.
Linear Polyethylene Wear versus Cytokine Concentrations (d)
The concentrations of each of the relevant inflammatory cytokines was compared
to the linear polyethylene wear measurements for each sample. Cytokine levels that were
below the limits of detection were not included in these comparisons, however, those that
were above the limits of detection were included, with their value being the maximum
detectable limit. Direct comparisons were done between the two variables and a linear
trendline was applied to determine how significant this correlation was. However, since
nothing was found in literature applying any specific trend to assess this type of data, the
variables were also ranked (one rank for the polyethylene wear and one rank for cytokine
concentrations) for each sample, and those ranks were plotted against one another to
determine if there was any significance in these comparisons. The direct comparison and
the ranked comparison for the five relevant inflammatory cytokines can be seen in
Figures 3-18 through 3-27. The correlation coefficients, confidence interval for the
correlation, and Pearson rank p-values for each comparison can be seen in Tables 3-13
and 3-14, and the correlation coefficients, confidence interval for the correlation, and
Pearson Rank p-values once outliers were removed can be seen in Tables 3-15 and 3-16.
Metal Ion Concentrations versus Cytokine Concentrations (e)
The cytokine concentrations for the cytokines that had values within the limits of
detection (IL-6, MCP-1, IL-1β, MIP-3α, and M-CSF) were compared to the cobalt,
chromium, and titanium levels for each implant. There were thirteen samples for which
the cytokine values and metal levels were available, except for MCP-1 in which there
were only twelve available, due to one of the samples being below limits of detection for
the cytokine. Direct comparisons were done between the two variables and a linear
trendline was applied. The comparison of these two variables can be seen in Figures 3-28
through 3-42, and the correlation coefficients, confidence interval for the correlation, and
Pearson rank p-values for each comparison can be seen in Tables 3-17 through 3-19.

Metal Ion Concentrations versus Corrosion Scores (f)
Because the levels of corrosion were so low in these samples, graphical
representation did not give much insight into what relationships, if any, were evident. The
samples were divided into two groups, those with a head corrosion of 1 and those with a
head corrosion of 2, and a t-tests was completed between these two groups for each of the
three metals. There were five samples in the group with corrosion scores of 1, and seven
samples in the group with corrosion scores of 2. For cobalt, the Shapiro-Wilk normality
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Figure 3-12. Dissociation force compared cobalt levels in tissue
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Figure 3-13. Dissociation force rank compared cobalt level in tissue rank
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Figure 3-14. Dissociation force compared to chromium levels in tissue
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Figure 3-15. Dissociation force rank compared to chromium levels in tissue rank
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Figure 3-16. Dissociation force compared to titanium levels in tissue
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Figure 3-17. Dissociation force rank compared to titanium levels in tissue rank
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Table 3-11. Correlation coefficients and p-values for the direct comparison of
each metal ion type to dissociation force

Metal
Cobalt
Chromium
Titanium

Sample Size
11
11
11

95%
Confidence
Interval of r
-0.062 to 0.87
0.11 to 0.90
-0.76 to 0.37

Correlation
Coefficient (r)
0.56
0.66
-0.30

P-Value
0.07
0.03
0.4

Table 3-12. Correlation coefficients and p-values for the ranked comparison of
each metal ion type to its dissociation force

Metal
Cobalt
Chromium
Titanium

Correlation
Coefficient (r)
0.30
0.21
-0.14

Sample Size
11
11
11

95%
Confidence
Interval of r
-0.36 to 0.76
-0.45 to 0.72
-0.68 to 0.50
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Figure 3-18. IL-6 concentration compared to the polyethylene wear
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Figure 3-19. IL-6 rank among all samples compared to the polyethylene wear rank
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Figure 3-20. MCP-1 concentration compared to the polyethylene wear
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Figure 3-21. MCP-1 rank among all samples compared to the polyethylene wear
rank

2

Polyethylene Wear (mm)

1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
R² = 0.0347

0
0

500

1000

1500

2000

2500

3000

3500

4000

IL-1B (pg/ml)

Figure 3-22. IL-1β concentration compared to the polyethylene wear
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Figure 3-23. IL-1β rank among all samples compared to the polyethylene wear
rank
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Figure 3-24. MIP-3α concentration compared to the polyethylene wear
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Figure 3-25. MIP-3α rank among all samples compared to the polyethylene wear
rank
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Figure 3-26. M-CSF concentration compared to the polyethylene wear

51

12

Poly Wear Rank

10
8
R² = 0.004
6
4
2
0
0

2

4

6

8

10

12

M-CSF Rank

Figure 3-27. M-CSF rank among all samples compared to the polyethylene wear
rank

Table 3-13. Correlation coefficients and p-values for the direct comparison of
each cytokine to its polyethylene wear
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
11
10
11
10
11

Correlation
Coefficient (r)
0.25
0.094
-0.19
-0.14
-0.017
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95% Confidence
Interval of r
-0.42 to 0.74
-0.57 to 0.68
-0.71 to 0.47
-0.71 to 0.54
-0.61 to 0.59

PValue
0.5
0.8
0.6
0.7
0.9

Table 3-14. Correlation coefficients and p-values for the ranked comparison of
each cytokine to its polyethylene wear
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
11
10
11
10
11

Correlation
Coefficient (r)
0.37
0.31
-0.58
0.091
0.063

95% Confidence
Interval of r
-0.30 to 0.79
-0.40 to 0.79
-0.88 to 0.027
-0.57 to 0.68
-0.56 to 0.64

PValue
0.3
0.4
0.06
0.8
0.9

Table 3-15. Correlation coefficients and p-values for the direct comparison of
each cytokine to its polyethylene wear with outliers removed
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
11
8
9
8
11

Correlation
Coefficient (r)
0.25
0.57
-0.25
-0.074
0.017

95% Confidence
Interval of r
-0.42 to 0.74
-0.22 to 0.91
-0.79 to 0.49
-0.74 to 0.67
-0.59 to 0.61

PValue
0.5
0.1
0.5
0.9
0.9

Table 3-16. Correlation coefficients and p-values for the ranked comparison of
each cytokine to its polyethylene wear with outliers removed
Cytokine
IL-6
MCP-1
IL-1β
MIP-3α
M-CSF

Sample
Size
11
8
9
8
11

Correlation
Coefficient (r)
0.37
0.39
-0.36
0
0.063
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95% Confidence
Interval of r
-0.30 to 0.79
-0.43 to 0.86
-0.83 to 0.40
-0.70 to 0.70
-0.56 to 0.64

PValue
0.3
0.3
0.3
1.00
0.9
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Figure 3-28. Cobalt levels in tissue compared to IL-6 levels in synovial fluid
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Figure 3-29. Chromium levels in tissue compared to IL-6 levels in synovial fluid
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Figure 3-30. Titanium levels in tissue compared to IL-6 levels in synovial fluid
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Figure 3-31. Cobalt levels in tissue compared to MCP-1 levels in synovial fluid
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Figure 3-32. Chromium levels in tissue compared to MCP-1 levels in synovial fluid
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Figure 3-33. Titanium levels in tissue compared to MCP-1 levels in synovial fluid
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Figure 3-34. Cobalt levels in tissue compared to IL-1β levels in synovial fluid
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Figure 3-35. Chromium levels in tissue compared to IL-1β levels in synovial fluid
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Figure 3-36. Titanium levels in tissue compared to IL-1β levels in synovial fluid
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Figure 3-37. Cobalt levels in tissue compared to MIP-3α levels in synovial fluid
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Figure 3-38. Chromium levels in tissue compared to MIP-3α levels in synovial fluid
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Figure 3-39. Titanium levels in tissue compared to MIP-3α levels in synovial fluid
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Figure 3-40. Cobalt levels in tissue compared to M-CSF levels in synovial fluid
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Figure 3-41. Chromium levels in tissue compared to M-CSF levels in synovial fluid
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Figure 3-42. Titanium levels in tissue compared to M-CSF levels in synovial fluid

Table 3-17. Correlation coefficients and p-values for comparison between
cytokines and cobalt levels
Cytokine
IL-6
MCP-1
IL-1B
MIP-3a
M-CSF

Sample
Size
13
12
13
13
13

Correlation
Coefficient (r)
0.67
0.76
-0.25
0.60
-0.22

95% Confidence
Interval of r
0.19 to 0.89
0.33 to 0.93
-0.71 to 0.35
0.031 to 0.87
-0.69 to 0.38

P-Value
0.01
0.004
0.4
0.04
0.5

Table 3-18. Correlation coefficients and p-values for comparison between
cytokines and chromium levels
Cytokine
IL-6
MCP-1
IL-1B
MIP-3a
M-CSF

Sample
Size
13
12
13
13
13

Correlation
Coefficient (r)
-0.11
0.025
-0.14
0.13
-0.19
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95% Confidence
Interval of r
-0.62 to 0.47
-0.56 to 0.59
-0.64 to 0.45
-0.45 to 0.64
-0.67 to 0.40

P-Value
0.7
0.9
0.7
0.7
0.5

Table 3-19. Correlation coefficients and p-values for comparison between
cytokines and titanium levels
Cytokine
IL-6
MCP-1
IL-1B
MIP-3a
M-CSF

Sample
Size
13
12
13
13
13

Correlation
Coefficient (r)
-0.28
-0.18
-0.11
-0.11
0.20
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95% Confidence
Interval of r
-0.72 to 0.32
-0.68 to 0.44
-0.63 to 0.47
-0.62 to 0.47
-0.40 to 0.67

P-Value
0.4
0.6
0.7
0.7
0.5

test did not pass, so a Mann-Whitney Rank Sum test was performed to determine if there
was a significant difference between the two groups. The p-value for this test was 0.6,
meaning that a statistically significant difference was not able to be determined. For
chromium, the normality test also failed, and the Mann-Whitney Rank Sum test showed
similar results, a p-value of 0.5. Therefore, a significant relationship could not be
confirmed. A Mann-Whitney Rank Sum test was also performed for titanium, as it was
also non-normal. This test gave a p-value of 0.8, so there was no statistically significant
relationship between these groups either.

63

CHAPTER 4.

DISCUSSION

Summary
Because the implants studied in these groups were known to be well-functioning
with no loosening present, the hypothesis was that there would be low amounts of wear
and damage, along with low inflammatory cytokine values and metal ion levels. This
hypothesis was confirmed, as these implants all had minimal or mild corrosion, low
inflammatory cytokine concentrations overall, and relatively low polyethylene wear,
although this study did not allow a wear rate to be calculated. It is difficult to say whether
metal ion content was on the lower end or not, as there are very few studies looking at
metal ion levels in tissue through ICP-MS (most of the known levels are in serum).
Although the levels of most of these factors were expected to be low, the hope was a
relationship could be established between dissociation force and cytokine concentrations,
dissociation force and metal ion concentrations, polyethylene wear and cytokine
concentrations, metal ion concentrations and cytokine concentrations. There was also
expected to be a difference in dissociation force and metal ion content at different levels
of corrosion, with dissociation force decreasing as corrosion increased, and metal ion
content increasing as corrosion increased. One hypothesis was that a negative relationship
would exist between dissociation forces and inflammatory cytokine concentrations,
because a higher dissociation force should mean the connection is more intact, therefore,
there should be less metallic debris and less of an inflammatory response. Two cytokines
had moderate positive correlations to the dissociation force (MCP-1: r=0.64, CI: 0.011 to
0.90; MIP-3α: r=0.67, CI: 0.069 to 0.91), however, these were more due to one data point
pulling the trend in a positive direction, as seen by the wide confidence intervals. A
second hypothesis was that a positive relationship would exist between polyethylene
wear and cytokine values because as polyethylene debris are released, monocytes and
macrophages secrete cytokines to help manage the polyethylene debris. However, in this
study, there were no strong correlations for any of the comparisons between cytokines
and polyethylene wear. Another hypothesis was that a positive relationship would exist
between cobalt and titanium and some inflammatory cytokines (specifically IL-6, MCP1, TNF-α, IL-8). The concentrations of TNF-α and IL-8 were not within range to allow
for comparison of these cytokines to any other factors. Nothing in literature suggested a
relationship between chromium and inflammatory cytokines. In this study, there was no
meaningful correlation between titanium or chromium and any cytokines, as these
comparisons all had very low correlation coefficients. However, when looking at cobalt,
meaningful relationships seemed to emerge for IL-6 (r=0.67, CI: 0.19 to 0.89), MCP-1
(r=0.758, CI: 0.326 to 0.928), and MIP-3α (r=0.60, CI: 0.066 to 0.86). The relationship
between cobalt and IL-6 and MCP-1 was not surprising based on other findings in
literature, but it is typically not associated with a change in MIP-3α. The confidence
intervals seem to show some promise for a positive relationship between cobalt and
MCP-1 and IL-6, but the lower end of the confidence interval for MIP-3α is almost zero,
meaning a relationship between these two factors seems less likely. A fourth hypothesis
was that the relationship between the metal ions and dissociation forces would be
negatively related, but a moderate positive correlation was seen for cobalt (r=0.59, CI: -

64

0.062 to 0.87) and chromium (r=0.66, CI: 0.11 to 0.90). Although this is opposite of what
was hypothesized, there seems to be one data point in each of these comparisons that is
pulling the trend line to be as moderately positive as it is. The confidence interval for
cobalt and dissociation force includes zero. More research should be done to include
implants with varying degrees of corrosion and varying dissociation forces in order to
make any meaningful conclusions about these comparisons. Finally, there was no
detectable difference in metal ion content or dissociation forces between minimally and
mildly corroded implants. A difference may have been able to be detected with a broader
spread of corrosion, but with such low corrosion being seen in these implants, no
difference was able to be detected.
The fact that this study contained well-functioning implants with low levels of
damage and inflammatory cytokine content made it difficult to identify potential
relationships, as the cytokine values were mostly the same for each sample, while the
other factors such as dissociation force and polyethylene wear were more variable. While
this factor made it difficult to identify potential relationships, these values were also very
preliminary with only fourteen samples. As more samples are added, the hope is that
more defined relationships will emerge for each of these comparisons. While this study
did not necessarily provide meaningful information about how these values are related to
one another, it is a step in the right direction for understanding what makes certain
implants work well. There is a lack of retrieval studies on well-functioning implants, and
therefore it is difficult to establish baseline values for comparison when looking at failed
implants. This study will be continued with the addition of these failed implants in the
future, and this will hopefully help to solve some of the mystery around what factors lead
to implant failures, and what factors are crucial for their success.
Inflammatory Cytokine Concentrations
The two groups assessed for the inflammatory cytokine testing were an
osteoarthritis control group (sample size of 16) and a well-functioning cadaveric implant
group (sample size of 14). Values were expected to be on the lower end of the detectable
range of the cytokine concentrations for each of these groups. These low levels were
expected for the osteoarthritis control group because the cytokines selected were mostly
associated with the body’s response to wear debris that may contribute to bone
resorption, and since the samples in this group did not have an implant yet in the joint of
interest, the concentrations of many of these were expected to be low. In the cadaveric
implant group, the values were expected to be low because, again, the cytokines selected
were cytokines that are known to contribute to the RANK/RANKL pathway that can lead
to aseptic loosening, and fluoroscopic images of these implants showed there was no
aseptic loosening present in the joint. Bone cement particles can also cause an
inflammatory response leading to higher concentrations of these cytokines, but none of
these implants had cemented acetabular cups, and only two implants had cemented
femoral stems, so the bone cement debris is not considered to play a major role in the
cytokine concentrations. While there were a few samples in each group with slightly
elevated values of one particular cytokine, as a whole, these values were very close to the
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lower limit of detection. This makes it difficult to establish any meaningful correlations
with these values, as there is not a good spread of the data across the entire detection
range, however, it does create a good “baseline value” for use with comparing with
groups of revision or failed total hip arthroplasty.
For TNF-α, the osteoarthritis group had only five out of the sixteen within range.
The mean of these five was 9.37 pg/ml. The cadaveric implant group had only five of the
fourteen within range, and the mean of these five was 10.8 pg/ml. The detection limits for
TNF-α ranges from 8.9-2170 pg/ml, so the means of these two groups are only barely
within detection limits, and therefore it can be concluded that TNF-α was not present in
meaningful concentration in either group. This is not surprising for a couple of reasons.
For one, as mentioned earlier, elevated levels of any of these cytokines were not
expected. Secondly, the half-life of TNF-α is very low, only around five to eight minutes
[42]. There have been studies addressing TNF-α in revision arthroplasties, however, most
of these are obtaining a number of cells containing TNF-α in the tissue surrounding the
implant, not assessing the levels of TNF-α in synovial fluid. Therefore, a direct
comparison of the levels obtained in this study to levels of failed implants in literature is
difficult.
For IL-6, the osteoarthritis group had seven of the sixteen samples within range,
with the remaining nine being above the limit of detection. The mean for the
concentrations for this group was 808 pg/ml. For the cadaveric implant group, twelve of
the fourteen samples were within range with the remaining two samples being above the
limits of detection. The mean of the group was 433 pg/ml. The detectable range of IL-6 is
4.9-1180 pg/ml. This particular cytokine was more elevated in the osteoarthritis group
than it was in the cadaveric group, but this difference was not found to be significant
when using a Mann Whitney test. Values for the half-life of IL-6 are found to have a
range in literature, with one study reporting a value of about 103 minutes [43]. The levels
of this particular cytokine are intriguing, because unlike the majority of the cytokines,
this one is actually relatively elevated. IL-6 is known to be secreted by osteoblasts to
induce osteoclast formation, so it is interesting that it would be slightly elevated in the
groups in which there was no implant present (osteoarthritis) or in which there is an
implant with no sign of aseptic loosening (well-functioning implant group). This cytokine
has also been shown in literature to be related to periprosthetic joint infections, in which
there would be inflammation present to try to remove the infection [28]. This cytokine
was shown to be elevated in the serum of total joint revisions, but an exact level was not
given [44]. Because the cytokine was more elevated in the osteoarthritis group, it may be
interesting to further study whether or not this cytokine may play a role in the body’s
response to osteoarthritis in a joint.
For IL-8, the osteoarthritis group had fifteen out of the sixteen samples in range,
with one above the limits of detection. This one sample drove the mean of the group up to
124 pg/ml, but without this sample, the mean of the group was only 57 pg/ml. However,
for the cadaveric implant group, eleven out of the fourteen were above the limits of
detection, with the mean of this group being 977 pg/ml. The detectable range of this
group is 4.7-1140 pg/ml. For this cytokine, the cadaveric group was significantly more
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elevated than seen in the osteoarthritis control group, with a p-value of less than 0.001
when using a Mann Whitney test to compare. While this cytokine was almost nonexistent in the osteoarthritis group, it was very close to the upper limit of detection for the
cadaveric group. This cytokine, similarly to IL-6 is known to play a role in osteolysis and
aseptic loosening. Studies found elevated levels of IL-8 in total joint replacements
undergoing revision when compared to primary replacements for OA [27]. However, this
study did not include well-functioning implants at time of death, so it is difficult to say
whether these results of elevated IL-8 in the cadaver group are abnormal. Because these
joints have been checked with fluoroscopy for aseptic loosening and no signs of
loosening were seen, this cytokine may play a role in the healing mechanisms that is
unrelated to aseptic loosening. The production of IL-8 is known to be enhanced by TNFα, IL-1, and IL-3 [45], however, the levels of IL-1 and TNF-α in this study was relatively
low. More work should be done to determine potential causes for elevated IL-8 that are
unrelated to aseptic loosening.
For MCP-1, all sixteen of the osteoarthritis samples were within range with a
mean of 864 pg/ml. For the cadaver samples, eleven out of fourteen of the samples were
within range with a mean of 1493 pg/ml. The range of this cytokine is 98-7940 pg/ml, so
these means are on the lower end of this range. There was no detectable difference
between these two groups. While there is no recorded half-life for MCP-1 in literature,
MCP-1’s role is to recruit macrophages to a site when needed, as monocytes, which
mature into macrophages, are thought to leave circulation by about 340 million each day
[46]. Because the detectable limit of this cytokine goes up to 7940 pg/ml, a mean value of
1493 pg/ml is considered to still be relatively low. While it is not statistically different
than the mean of the levels in the osteoarthritis group, a reason it could have a slightly
higher mean is that, while these are well-functioning implants, wear debris are still being
produced in the joint daily. As these are being produced, monocytes are recruited to the
joint to engulf and phagocytize these debris. Therefore, it would be expected for some
level of MCP-1 to be present in any joint that has a joint replacement. This cytokine may
be related to aseptic loosening in cases where there is so much wear debris present, the
macrophages are unable to keep up with the demand and bone resorption begins to take
place. However, that was not the case in the groups tested in this study.
For IL-1β, all sixteen of the osteoarthritis samples were below detectable limits,
so no mean could be obtained, but all fourteen of the cadaveric samples were in range
with a mean of 376. Although the samples were within range, the detectable range for IL1β is 16.3-3950 pg/ml, so a mean of 376 is, again, very low on the detection range. IL-1β
is a key mediator of the inflammatory response, and is essential for host response to
pathogens. It is known to exacerbate damage during chronic disease and acute tissue
injury. IL-1β is also known to have a very short half-life, although an exact value could
not be found in literature [47]. Because of this short half-life, it is difficult to say whether
or not the levels seen in the cadaveric group may have been higher initially. However,
because these implants were known to be well-functioning, IL-1β would not need to be
secreted in high amounts because there was no acute tissue injury. This cytokine would
be expected to be high at the time of implantation, as there is severe tissue injury and
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healing that must take place, but as the body adapts to the implant being present in the
joint, the need for IL-1β secretion would be low.
For MIP-3α, the osteoarthritis group had fifteen out of sixteen samples within
range, with a mean of 21 pg/ml. The cadaveric group had eleven out of fourteen within
range. One of these was above detection, while the other two were below detection. The
mean of this group was 191, but if the sample above detection is excluded, the mean
drops to 34. With a detectable range for MIP-3α of 7.9-1920 pg/ml, neither group had
significant concentrations of this cytokine in the synovial fluid. There was no significant
difference found between these two groups. Similarly to MCP-1, literature cites a short
half-life for chemokines such as MIP-3α, but an exact number is not given [48].
Literature does not specifically address how MIP-3α relates to aseptic loosening, but it is
known to be a cytokine that is strongly chemotactic to lymphocytes and is produced by
osteoclast cells. It may potentially play a role in aseptic loosening by recruiting
lymphocytes in response to polyethylene debris, and contributing to the RANKL pathway
leading to osteoclastogenesis and bone loss. However, because it has not been studied in
this particular application before, there are no values in literature about levels of MIP-3α
in total joint replacements. More work should be done to determine what type of role this
cytokine plays in aseptic loosening.
For IL-2, the osteoarthritis group had seven out of sixteen samples below
detection, with a mean of 40 pg/ml. The cadaver group had ten out of the fourteen
samples below the limit of detection, with a mean of 42 pg/ml. The limits of detection for
IL-2 are 35-8510 pg/ml, so these means are extremely low, so IL-2 is essentially
negligible in these two sample groups. There is no statistical difference between the two
groups. These values are very low, which is not unexpected because IL-2 has a half-life
of 3.7 minutes [49]. Because this cytokine has such a short half-life, the values obtained
in this study do not give much information. In order to get valuable and accurate
concentrations for this cytokine, synovial fluid would need to be aspirated and frozen
almost immediately after death for the cadaveric groups. The synovial fluid is spun for
twenty minutes after obtaining it and before freezing it, which gives time for the levels to
decrease dramatically. Therefore, from a practicality standpoint, this cytokine may not be
the most useful for this application.
Finally, for M-CSF, the osteoarthritis group had two out of sixteen samples below
the limit of detection with a mean of 1372 pg/ml. The cadaver group had all fourteen
samples within range with a mean of 52054 pg/ml. The limits of detection for M-CSF are
514-124810 pg/ml, so these are still fairly low considering the full range of the cytokine.
The differences between these two groups were found to be significant, with a p-value of
<0.001 after completing a Mann-Whitney test. While studies have shown that this
cytokine is present in revision cases and contributes to the RANKL pathway for aseptic
loosening, this observation has typically been made by observing that there is M-CSF
present in the cells of the tissue, so these results cannot be directly compared to the
results of this study [50]. A study by Takei reported higher M-CSF levels in the fluid of
loose hip joints when compared to mild OA, but this study did not test M-CSF levels in
joints that had no problems evident [51]. While this cytokine was significantly higher in
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the cadaver group compared to the OA group, it is still only at a level that is one-fifth the
upper limit of detection. This cytokine is responsible for influencing hematopoietic stem
cells to differentiate into macrophages or similar cell types, so it would be expected to be
at least slightly elevated in the cadaver group, as some wear debris is always being
produced and macrophages need to be recruited to assist with that. However, in a group
of revision failed implants, these values would be expected to be much higher, as the
larger amount of wear debris would necessitate more macrophages to be present. M-CSF
is critical for osteoclast differentiation and is known to enhance osteoclast survival, so in
joints where aseptic loosening is present, this cytokine may play a crucial role [52].
Although there were significant differences seen between the two groups for IL-8,
IL-1β, IL-2, and M-CSF, the limitations of these need to be taken into considerations.
Each of these groups had low sample sizes, fourteen in the cadaver group and sixteen in
the osteoarthritis group. In some cases, one sample in a group has elevated concentrations
of a particular cytokine not seen in the other samples. As a result, the mean is driven
slightly upward causing a difference to be seen between the groups. If Tables 3-2 and 3-3
are studied, one can observe that most of the cytokines concentrations are fairly close to
one another on the low end of detection, and therefore, are not considered to be
contributing to inflammation in a meaningful way. However, the numbers will be useful
moving forward into revision and failure studies for hip implants as a baseline value for
comparison.
Corrosion Scores
As mentioned previously, the corrosion scores were very low for the retrieved
implants. There were sixteen retrieved implants that the corrosion scoring was completed
for. For the male portion of the taper, fifteen out of the sixteen implants received a
corrosion score of 1, with the other implant receiving a score of 3. Therefore, these
particular numbers were not useful in creating a correlation from male taper damage to
any of the other factors studied. However, for the female portion of the taper, eight of the
sixteen implants were scored a 2, six of the sixteen implants were scored a 1, and the
remaining two were ceramic heads. Therefore, these were split into two groups to see if a
difference could be detected in the dissociation forces between the implants with a head
score of 1 and the implants with a head score of 2. However, the Shapiro Wilk test
showed no detectable difference. This is understandable, because even though the
implants were characterized with two different corrosion scores, the scores are
representative of minimal (1) and mild (2) damage, and the scoring system continues up
to moderate (3) and severe (4). The implants in this group were well-functioning implants
in which problems were not seen in the patient before death, and therefore, these low
damage scores are detected. A difference in the dissociation forces may have been seen
between groups with a broader range of corrosion scores, for example, comparing
minimal and severe, however, with these components being so slightly damaged, it is not
unexpected that there was no detectable difference in dissociation forces here. It should
be noted that there were different taper designs in this study. There are eight tapers that
are known to be a 12/14 type taper, and one that was a 16/18 type taper. Because there
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were not significant samples with different taper types, no conclusions can be drawn
about which taper designs may be more prone to corrosion than others.
Polyethylene Wear Measurements
The polyethylene wear measurements were only able to take into account how
much wear was present in linear thickness loss, and could not consider the causes of the
loss or produce a rate. The average polyethylene wear was 0.296 mm when including the
outlier of 1.867 mm, but dropped to 0.184 mm when excluding this outlier.
Unfortunately, one weakness in this measurement is that a wear rate cannot be
determined since there is no year of implantation for these implants. Therefore, the
measurements must be taken as standalone values of how much polyethylene has been
worn down, and cannot conclude anything about the frequency or mechanism that led to
the wear. The reported wear rate for highly cross-lined polyethylene is reported to be
very low, between 0.00 and 0.01 mm/year in the first three years, with no wear rates
higher than 0.1 mm/year in one study [53]. Another study reported a mean linear
polyethylene rate of 0.11 mm/year, with a range of 0-0.86 mm/year [54]. The average
polyethylene wear was 0.184 mm for this study, and although it is unknown how long the
implants were in place before death, this seems to be a relatively low amount of wear
considering averages reported around 0-0.1 mm/year. Therefore, as assumed with these
well-functioning prostheses, relatively low wear is present. Apart from knowing a
specific wear rate, one factor that could aid in better understanding these results would be
to know the mechanism of wear. This factor will be assessed in the future by noting
damage scores on the femoral heads, as well as seeing if particular modes of damage are
evident in the polyethylene liners. Another thing to consider when studying polyethylene
wear is the head size of the implant. In this study, five implants had 28 mm heads, five
implants had 32 mm heads, four implants had 36 mm heads, and two implants had 40 mm
heads. Of these implants, linear wear measurements were obtained for three liners of
implants with 28 mm heads, four liners of implants with 32 mm heads, four liners of
implants with 36 mm heads, and two liners of implants with 40 mm heads. The mean of
each of these groups were 0.954 mm (28 mm), 0.112 mm (32 mm), 0.193 mm (36 mm),
and 0.114 mm (40 mm). This shows the highest wear was seen in the implants with the
smallest head size, which is conflicting with what is shown in literature. However, the
fact remains that the implantation time for these implants is unknown, and it is difficult to
compare means of groups with such small sample sizes, between two and four implants
per group. However, it is important to note that the head sizes of these implants can affect
the polyethylene wear rates, and this should be tracked moving forward.
ICP-MS Analysis
The values obtained in this study were much higher than what was seen in
literature, however, these values are difficult to find in literature, and the values that are
found are typically reported from serum. To this date, no values were found in literature
studying the cobalt, chromium, and titanium levels in the tissue surrounding total hip
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implants. In the study by Savarino et al mentioned in the introduction, the levels for
cobalt and chromium in patients with a metal on polyethylene bearings were 0.64 µg/L
and 0.60 µg/L, respectively, however, these were the values from the patient’s serum. In
this study, because the values were obtained by analysis of the anterior and posterior
capsular tissue, the results were expected to be higher because the metal debris remains in
the localized area instead of being diluted throughout the body, as in serum. In this study,
the average value seen for cobalt was 35.80 µg/L, for chromium was 139.46 µg/L, and
for titanium was 28.84 µg/L. The full set of results can be seen in Table 3-6. Out of the
seventeen samples metal ion levels were able to be obtained for, nine had a cobalt
chromium/titanium taper combination, four had a cobalt chromium/cobalt chromium
taper combination, two were a ceramic/titanium taper combination, and two did not have
the metal bearing types available at this time. While only four of the implants in this
study did not include titanium as a metal, seven of the implants had a titanium level of 0.
While the cobalt and chromium levels were low for several of the samples, they did not
have any values of 0, while seven of the samples had titanium values of 0. One potential
reason for this is the “blank” samples used in the analysis actually had an average
titanium value of 8.4 µg/L. The levels of each ion for the blanks was subtracted from the
reported value, so this could mean there were samples with very low values of titanium
that may have been overlooked due to background noise in the samples. Another reason
could be, as mentioned before, since these are well-functioning implants, values could be
low. The corrosion scores for the stems of almost all the implants were 1, except for one
implant which was scored a 3. This low corrosion seen in the stems of the samples could
also explain the low titanium ion levels seen in the samples. This relationship will be
further explored in the sections comparing metal ion levels to other factors.
Dissociation Force versus Cytokine Concentrations (a)
The hypothesis for this comparison was that as dissociation force increased,
cytokine concentration would decrease, as a higher dissociation force should mean the
taper connection is more intact. Therefore, there is less corrosion and material loss in the
taper connection and hopefully less of an inflammatory response to debris. However, it
should be noted that cytokine concentrations may go up due to polyethylene debris as
well. When comparing the dissociation force for each implant to the various cytokine
concentrations and trying to determine if any correlations exist, two different methods
were used. These were simply compared number-to-number (the cytokine concentrations
to the dissociation force) to look for correlations, as well as rank-to-rank, in which the
rank for each individual implant’s dissociation force and cytokine concentration amongst
the group was used. This was done in an attempt to standardize the numbers. However,
because these were well-functioning implants and the cytokines were mostly clustered
around the lower limit of detection, it was difficult to ascertain any meaningful
correlations. With a broader spread of cytokine concentrations, a better conclusion may
have been able to be drawn about how these factors relate. As it is, there were only two pvalues considered to be significant (<0.05) when looking at these comparisons. The first
was found when the concentration of MCP-1 was directly compared to the dissociation
force of the implants, and this produced a p-value of 0.05. MCP-1 is the main chemokine
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responsible for recruiting monocytes. These monocytes can then mature into
macrophages, which are the main scavenger cells of the immune system that attempt to
find and phagocytize foreign bodies. This comparison gave a positive correlation of 0.64,
which is contrary to what was hypothesized. It is believed that a higher dissociation force
means that the taper connection should be more intact, meaning less wear debris is being
produced and therefore the need for monocytes to assist in removal of wear debris is
lower. However, this belief will be further explored when directly comparing the
cytokine concentrations to the metal ion content in the tissue. One reason this positive
correlation could be seen is that when looking at the graph in Figure 3-4, there is one
data point that seems to be pulling the graph in a positive direction. The confidence
interval for the correlation coefficient for this comparison was 0.011 to 0.90. Therefore,
while the correlation between these two variables was moderate (0.64), the 95%
confidence interval states that the actual correlation coefficient could fall anywhere from
0.011 to 0.90 with 95% confidence. This is likely due to the fact that there is a low
sample size in this comparison, with one value that is much different than the others
pulling the trend in a more positive direction. This data point was considered to be an
outlier for the MCP-1 concentrations, and when it was removed, the p-value for this
comparison increased to 0.9. Based on the 95% confidence interval and low p-value
when outliers are removed, it is not possible to say with certainty what the relationship
between these two factors is. In order to see a relevant comparison between these two
factors, the sample size of the group would need to be increased, and a wider spread of
cytokines would be necessary. The second significant correlation was the direct linear
comparison of the concentration of MIP-3α to the dissociation force of the implants,
producing a p-value of 0.03. MIP-3α is a cytokine that is strongly chemotactic to
lymphocytes. These lymphocytes can play a role in the RANK/RANKL pathway which
can lead to bone resorption, which is why it is relevant in this application. Similarly to
MCP-1, a negative correlation was hypothesized to be seen for this, but instead a positive
correlation of 0.67 was seen. However, when a 95% confidence interval was completed
for the correlation coefficient, a range of 0.069 to 0.91 was found to be the interval.
Similarly to MCP-1, there were two data points that pulled the trend line in the strong
positive direction, which is likely why there was a higher correlation coefficient between
these factors. Because the confidence interval again goes from almost 0 to almost 1, it is
difficult to confidently state any relationship between these two variables based on the
data, as there is 95% confidence that the true correlation coefficient could fall anywhere
within that range. There were two outliers in this comparison as well that, when removed,
increased the p-value to 0.9. Therefore, again, a larger sample size would be needed with
a better spread of data points in order to say anything conclusive about this correlation.
With outliers removed, this correlation does not appear to have any significance. The
remainder of the correlation coefficients for the comparisons ranged from 0.066 to 0.44,
which did not produce any significant p-values and had wide confidence intervals for the
correlation coefficients. This was not surprising, because, as mentioned previously, the
cytokine values were so low on the limits of detection, the spread of the data makes it
difficult to see any correlations.
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Dissociation Force versus Corrosion Scoring (b)
The hypothesis for this comparison was that implants that were more highly
corroded would have a lower dissociation force due to material loss than those implants
with less corrosion. Unfortunately, for this study, this hypothesis was not able to be tested
thoroughly, as the implants in this study were minimally corroded. For the trunnion, all
implants except one had a corrosion score of 1, or minimal. For the bores, all implants
were scored either a 1, minimal, or 2, mild. There was no significant difference in
dissociation forces between these two groups. In order to better explore this hypothesis, a
broader spread of corrosion scores would be needed.
Dissociation Force versus Metal Ion Concentrations (c)
Positive relationships were seen for the comparisons of cobalt and chromium
levels in tissue to the dissociation forces of the implants, and a very slight negative
relationship was seen for the comparison of titanium levels in the tissue to the
dissociation forces of the implants. The titanium relationship is affected by the fact that
five out of the eleven samples had a titanium value of zero, so a relationship may be
difficult to determine, as well as the fact that there is one titanium value significantly
more elevated than the rest. Upon further analysis, this value was found to be an outlier.
When directly comparing the cobalt levels to the dissociation forces, a p-value of 0.07
was seen, and when directly comparing the chromium levels to the dissociation forces, a
p-value of 0.03 was seen. While this seems to suggest a promising relationship between
these factors, it must also be noted that these values are obtained by using a Pearson -rank
coefficient, which assumes a linear relationship between the two variables. Because this
relationship has not been explored in literature, it is difficult to definitively say that this
relationship would be linear, however, it is a step in the right direction for future
exploration of this relationship down the road. A positive relationship was contrary to
what was hypothesized, because as micromotion at the articulation of the head and neck
of the implant occurs, the oxide layer can be broken down which leads to the release of
these metal ions. This can also lead to the corrosion of the surfaces, which can decrease
the strength of the taper connection. Therefore, higher concentrations of these metals
were expected to lead to a decrease in the dissociation force. However, when the
confidence interval of the correlation coefficient of each of these comparisons is
calculated, the positive relationship seems less likely. The confidence interval for the
correlation coefficient of the comparison of cobalt and dissociation force includes zero
(-0.062 to 0.87), which means that there is 95% confidence that the true correlation
coefficient falls anywhere within that range. The confidence interval for the correlation
coefficient of the comparison of chromium and dissociation force is 0.11 to 0.90.
Therefore, it cannot be confidently concluded that there is a positive relationship between
the presence of these metal ions and dissociation force, but it does seem to have slightly
more of a relationship than cobalt. There have been some studies with preliminary data
showing that more metal debris and therefore more corrosion can lead to a higher
dissociation force because of the increase in friction between the two surfaces, however,
this is for severely corroded implants and does not necessarily apply to this data set that
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only experienced minimal and mild corrosion. A broader set of implants with more
varying dissociation forces and corrosion forces may give more insight into this
relationship. One flaw in this comparison other than the wide confidence intervals that
could explain why the relationship is contrary to what is hypothesized could be that there
are other factors that contribute to the dissociation force that are unable to be controlled
in this study. For one, the assembly of the taper has been shown to greatly influence the
strength of the taper connection. For example, the force of the impaction of the head onto
the stem, the number of impactions, and whether the surfaces were wet or dry has been
shown to impact this taper strength. Because these cannot be controlled for, the
dissociation force must simply be taken as-is.
Linear Polyethylene Wear versus Cytokine Concentrations (d)
For this comparison, the linear polyethylene and cytokine values were both
directly compared, as well as ranked amongst all the samples and compared. For these
comparisons, no significant p-values were seen. There was one value approaching
significance (considered to be 0.05) when comparing the rank of IL-1β to the rank of the
linear polyethylene wear. The correlation was -0.58 with a p-value of 0.06. Similarly to
the two correlations seen previously when comparing the dissociation forces, this
correlation is opposite of what was hypothesized. A positive correlation was expected to
be seen when comparing polyethylene wear an IL-1β, because as polyethylene debris is
generated, macrophages attempting to engulf the debris secrete IL-1β in response.
However, the cytokine concentrations for IL-1β were all very close to the lower limit of
detection. The mean for these cytokines was 16.3-3950 pg/ml, and the average of these
samples was 376 pg/ml. Therefore, without a larger spread of cytokine values and with
such a small sample size, it is uncertain whether this negative trend would continue as the
sample size expands. This significance was also only seen in the ranked comparison
between the two groups. The direct comparison had a p-value of 0.6, so it is difficult to
say confidently that this negative correlation exists and is significant. In addition, there
was one outlier in the IL-1β concentrations, and when this outlier was removed, the pvalue for this comparison increased to 0.3, so the closeness to significance was, as
expected, most likely due to an outlier. Finally, when looking at the confidence interval
for the correlation coefficient for this data, it ranges from -0.88 to 0.027. Because this
confidence interval includes 0, it is difficult to confidently state a relationship between
these two variables based on this data. Based on this data alone, the correlation
coefficient could fall anywhere between -0.88 and 0.027 with 95% confidence. As with
the other comparisons in this study, more samples are needed in order to begin to solidify
if any of these relationships do actually exist.
Metal Ion Concentrations versus Cytokine Concentrations (e)
There were very few significant correlation between the cytokine concentrations
and metal ion levels. Chromium and titanium did not have any p-values below 0.4 for any
of the cytokines tested in this study. This was not surprising for chromium, as there is
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very little discussion in literature about a relationship between the presence of chromium
ions and an increase in the concentration of any inflammatory cytokines, however,
literature does show titanium may increase concentrations of IL-6, IL-8, MCP-1, and
TNF-α. While there were no promising results in this study suggesting a relationship
between chromium and titanium with the inflammatory cytokines tested, there were
several cytokines that seemed to show some promise in their relationships when
compared to cobalt. There was a positive relationship between cobalt and IL-6, with a
correlation coefficient of 0.67 and a p-value of 0.01. The 95% confidence interval for the
correlation coefficient of this comparison was 0.19 to 0.89. There was also a positive
correlation between cobalt and MCP-1, with a correlation coefficient of 0.76 and a pvalue of 0.004. The 95% confidence interval for the correlation coefficient of this
comparison was 0.33 to 0.93. Finally, there was a positive relationship between cobalt
and MIP-3α with a correlation coefficient of 0.60 and p-value of 0.04. The 95%
confidence interval for the correlation coefficient of this comparison was 0.031 to 0.87.
The remaining two cytokines had p-values of 0.4 and 0.5 for cobalt. It is interesting that
some distinct relationships emerge when observing cobalt with several of the cytokines,
but not titanium or chromium. In this study, the titanium levels were zero in almost half
of the samples, which could explain the lack of relationships able to be detected.
However, the mean level of chromium was 139 ppb while cobalt’s was 36 ppb, which
means there should have been enough chromium present to detect the emergence of
relationships between it and the cytokines. Cobalt and chromium also had the same
number of samples plotted against the cytokine values, so the sample size should not be
the main impactor of the lack of relationship. Because cobalt and chromium are both
found together in a CoCrMo alloy, more research should be done to observe why cobalt
seems to be having a stronger impact on the presence of inflammatory cytokines than
chromium does. This does match with what is found in literature, as there are very few
studies describing chromium impacting the levels of any inflammatory cytokines. It may
also be interesting to intentionally seek out cytokines that are known to be affected by
cobalt specifically, or chromium specifically, and note if relationships emerge with those
cytokines. However, based on these results, it seems that cobalt is the metal that
contributes more to the release of inflammatory cytokines, therefore may be the metal
that contributes more to the inflammatory response to metallic debris. There is
information in literature supporting the positive relationship seen between cobalt and ILand MCP-1, but there is not anything showing it to have a relationship to MIP-3α. When
looking at the confidence intervals for these three comparisons, the lower end of the
confidence interval of cobalt with IL-6 was a correlation coefficient of 0.19, which is a
mild correlation. The lower end of the confidence interval for the comparison of cobalt
and MCP-1 was 0.33, suggesting a moderate correlation even at the worst-case end of the
95% confidence interval. However, the confidence interval for the correlation coefficient
of the comparison between cobalt and MIP-3α had a very wide range, with its lower end
being almost zero (0.031). This is not surprising, as when looking at the graph of this
comparison, (Figure 3-37), there seems to be one data point pulling the trend line in the
positive direction, while the rest of the points seem to lie relatively flat. Based on this, the
wide range for the confidence interval is not surprising. Based on the data compiled from
this study, it does seem likely that the presence of cobalt ions has an effect on the
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concentrations of IL-6 and MCP-1 in the body. More research should be done to further
explore the extent of this relationship.
Metal Ion Concentrations versus Corrosion Scores (f)
When comparing the metal ion levels between the minimally corroded and mildly
corroded head groups, there were no statistically significant differences between the
groups. This lack of significance is not surprising, because there were so few samples in
each group, and the corrosion levels between groups considered a one and those
considered a two would be fairly close. Similarly to the results between dissociation
forces and corrosion scores, it would be interesting to compare these levels in a group
considered minimally corroded against a severely corroded group to see if differences in
the metal levels of the tissues emerge.
Limitations
The first limitation that has already been mentioned is the fact that the sample size
for this study is very low. While there were a total of nineteen implants in the study, they
were not all used for each portion of the study. Only fourteen of these contained enough
synovial fluid to test for inflammatory cytokines. Eighteen were able to be analyzed
through ICP-MS for metal ion content. Fifteen were able to be disassembled in order to
obtain a dissociation force for the implant. Sixteen were able to be scored for corrosion.
Fifteen were able to have the linear polyethylene wear tested. Therefore, most of the
comparisons between types of testing are limited to a sample size of fourteen due to the
inflammatory cytokine sample limitations. While everything was done to ensure as many
samples as possible were obtained, the study was limited by the number of cadavers
containing hip implants that could be obtained from our partner organizations (MERI and
Restore Life USA).
A second limitation, which has also already been mentioned in the discussion for
inflammatory cytokines, is that because these implants were well-functioning with no
signs of osteolysis, the cytokine values were very low. While not unexpected, this
limitation makes it difficult to draw meaningful conclusions when comparing with other
types of testing. A similar limitation was also seen with corrosion scoring, because again,
since the implants were well functioning and not damaged, the corrosion seen in the
groups was low. Therefore, the corrosion values were not very revealing about how
levels of corrosion relate to the other factors measured because only minimal and mild
corrosion values were seen. A similar issue was observed in the detection of metal ion
levels. While cobalt and chromium levels were able to be detected, the titanium levels
observed were very low, with nine samples having titanium levels of zero and most of the
other samples fairly close to zero. Only five samples had titanium levels higher than 10
ppb. This could link back to the low corrosion on the stems of the implants, and also the
fact that some of the implants had a cobalt chromium-cobalt chromium taper connection.
While this is a noted limitation, it is also a necessary one. This study is functioning on

76

well-functioning implants, and as such, the implants in the group will be minimally
damaged with a minimal negative reaction in the body. This study will be beneficial
moving forward into the testing of failed and damaged implants, because it gives a
baseline of values for a group of implants that will be functioning as expected. However,
it is important to continue to build on the number of implants in this group in order to
have a more meaningful sample size, which will hopefully allow for significant
conclusions to be drawn moving forward.
Thirdly, the polyethylene wear measurements are just that, a singular
measurement. As the duration of implantation is not known for this group of implants, a
specific wear rate was unable to be calculated. Therefore, this number must be taken as
is. A better polyethylene measurement as far as correlation goes would be to compare the
wear rate to whatever factor it is being compared with, as it somewhat standardizes the
polyethylene wear values. As it stands now, the values are all being treated as equal,
when in reality, some of the implants with higher polyethylene values could be from
twenty years ago, while some of the implants with lower values could have been fairly
recent. This factor adds an element of uncertainty into any comparisons we make using
polyethylene. This could also explain why no significance was shown when comparing
the cytokine values to the amount of polyethylene wear. When adding a group of
damaged implants in the future, wear rates should be used if possible.
Finally, a significant limitation in this study is the differences in the types of
implants. Because there are many different designs, alloy combinations, and taper
designs, it is not possible to state anything conclusively about which types may perform
better than others, as the sample sizes of each group are too small. In this study, there
were six Zimmer Trilogy, one Depuy Duraloc, four Smith & Nephew Reflection, two
Stryker Trident, one Zimmer Continuum, one Biomet Ringloc Constrained, and three
Depuy Pinnacle implants. There were also eight implants with a CoCrMo/Ti6AlV4 taper
combination, four with a CoCrMo/CoCrMo taper combination, and two with a
ceramic/Ti6AlV4 taper combination. There were eight implants with a 12/14 taper and
one implant with a 16/18 taper. Finally, there were four implants with a 28 mm head, five
with a 32 mm head, four with a 36 mm head, and two with a 40 mm head. With so many
different variables present, and such small sample sizes of each type, these must just be
taken as one large group of implants as they cannot be broken down into groups.
Therefore, it must be noted, that the results from this study are results from a variety of
designs and metal combinations. In order for conclusions to be drawn in the future about
how each of these factors may impact implant function, large sample sizes in each of the
groups would need to be gathered and results analyzed for each group.
Future Work
As mentioned previously, the focus moving forward will be to continue the same
types of testing explained in this study with a group of failed implants from patients
undergoing a total hip revision surgery. Institutional Review Board approval has been
obtained to begin collection of such devices, but there are not yet enough samples to
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begin analysis of this type of data. The implants studied for the purposes of this thesis
will hopefully aid in understanding the values obtained through the testing of the failed
devices by providing a baseline of values seen in successful devices. The end goal is to
see if there are any biological factors that may be indicative of problems with total hip
implants that may lead to failure. While nothing definitive about the relationships
between the numerous variables affecting the success of total hip implants can be
concluded from this study, it is a step in the right direction for better understanding what
causes implants to fail.
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